<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">96513</article-id><article-id pub-id-type="doi">10.7554/eLife.96513</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96513.4</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Deganutti</surname><given-names>Giuseppe</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8780-2986</contrib-id><email>ad5288@coventry.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Pipito</surname><given-names>Ludovico</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1824-7541</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Rujan</surname><given-names>Roxana Maria</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4335-3338</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Weizmann</surname><given-names>Tal</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Griffin</surname><given-names>Peter</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0966-800X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ciancetta</surname><given-names>Antonella</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Moro</surname><given-names>Stefano</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Reynolds</surname><given-names>Christopher Arthur</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9267-5141</contrib-id><email>ad5291@coventry.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01tgmhj36</institution-id><institution>Centre for Health and Life Sciences, Coventry University</institution></institution-wrap><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/041zkgm14</institution-id><institution>Dipartimento di Scienze Chimiche, Farmaceutiche ed Agrarie, University of Ferrara</institution></institution-wrap><addr-line><named-content content-type="city">Ferrara</named-content></addr-line><country>Italy</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00240q980</institution-id><institution>Molecular Modeling Section (MMS), Dipartimento di Scienze del Farmaco, University of Padua via Marzolo</institution></institution-wrap><addr-line><named-content content-type="city">Padova</named-content></addr-line><country>Italy</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/02nkf1q06</institution-id><institution>School of Life Sciences, University of Essex, Wivenhoe Park</institution></institution-wrap><addr-line><named-content content-type="city">Colchester</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Allen</surname><given-names>Toby W</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04ttjf776</institution-id><institution>RMIT University</institution></institution-wrap><country>Australia</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Cui</surname><given-names>Qiang</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05qwgg493</institution-id><institution>Boston University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>04</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP96513</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-02-21"><day>21</day><month>02</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-01-25"><day>25</day><month>01</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.10.26.513870"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-05-14"><day>14</day><month>05</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96513.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-17"><day>17</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96513.2"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-04-14"><day>14</day><month>04</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.96513.3"/></event></pub-history><permissions><copyright-statement>© 2024, Deganutti et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Deganutti et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-96513-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-96513-figures-v1.pdf"/><abstract><p>The structural basis for the pharmacology of human G protein-coupled receptors (GPCRs), the most abundant membrane proteins and the target of about 35% of approved drugs, is still a matter of intense study. What makes GPCRs challenging to study is the inherent flexibility and the metastable nature of interaction with extra- and intracellular partners that drive their effects. Here, we present a molecular dynamics (MD) adaptive sampling algorithm, namely multiple walker supervised molecular dynamics (mwSuMD), to address complex structural transitions involving GPCRs without energy input. We first report the binding and unbinding of the vasopressin peptide from its receptor V<sub>2</sub>. Successively, we present the complete transition of the glucagon-like peptide-1 receptor (GLP-1R) from inactive to active, agonist and G<sub>s</sub>-bound state, and the guanosine diphosphate (GDP) release from G<sub>s</sub>. To our knowledge, this is the first time the whole sequence of events leading from an inactive GPCR to the GDP release is simulated without any energy bias. We demonstrate that mwSuMD can address complex binding processes intrinsically linked to protein dynamics out of reach of classic MD.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>G protein-coupled receptors</kwd><kwd>G protein</kwd><kwd>binding</kwd><kwd>GLP-1R</kwd><kwd>molecular dynamics</kwd><kwd>supervised molecular dynamics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000268</institution-id><institution>Biotechnology and Biological Sciences Research Council</institution></institution-wrap></funding-source><award-id>BB/W016974/1</award-id><principal-award-recipient><name><surname>Reynolds</surname><given-names>Christopher Arthur</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000361</institution-id><institution>Diabetes UK</institution></institution-wrap></funding-source><award-id>BDA 20/0006307</award-id><principal-award-recipient><name><surname>Deganutti</surname><given-names>Giuseppe</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Multiple walker supervised molecular dynamics simulations deliver insights on glucagon-like peptide 1 receptor activation, G<sub>s</sub> protein binding, and guanosine diphosphate release from the G<sub>s</sub>α subunit using an adaptive sampling approach.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Supervised molecular dynamics (<xref ref-type="bibr" rid="bib18">Cuzzolin et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Deganutti et al., 2020b</xref>) (SuMD) is an efficient adaptive sampling technique for studying ligand-receptor binding and unbinding pathways; here, we present the multiple walker enhancement (mwSuMD) to study a significantly wider range of structural transitions relevant to the drug design. We validated the method by applying it to G protein-coupled receptors (GPCRs), since their inherent flexibility is essential to their function and because these are the most abundant family of membrane receptors in eukaryotes (<xref ref-type="bibr" rid="bib20">de Mendoza et al., 2014</xref>) and the target for more than one-third of drugs approved for human use (<xref ref-type="bibr" rid="bib91">Sriram and Insel, 2018</xref>).</p><p>Vertebrate GPCRs are subdivided into five subfamilies (Rhodopsin or class A, Secretin or class B, Glutamate or class C, Adhesion, and Frizzled/Taste2) according to function and sequence (<xref ref-type="bibr" rid="bib89">Schiöth and Fredriksson, 2005</xref>; <xref ref-type="bibr" rid="bib43">G protein-coupled receptors, 2019</xref>). X-ray and cryo-electron microscopy (cryo-EM) show that GPCRs possess seven transmembrane (TM) helices connected by three extracellular loops (ECLs) and three intracellular loops (ICLs), with an extended and structured N-terminal extracellular domain (ECD) in all subtypes, but class A. The primary function of GPCRs is transducing extracellular chemical signals into the cytosol by binding and activating four G protein families (G<sub>s/olf</sub>, G<sub>i/o</sub>, G<sub>12/13</sub>, and G<sub>q/11</sub>) responsible for decreasing (G<sub>i/o</sub>) or increasing (G<sub>s/olf</sub>) cyclic adenosine-3’,5’-monophosphate, and generating inositol-1,4,5-triphosphate and diacylglycerol to increase Ca<sup>2+</sup> intracellular levels (G<sub>q</sub>) (<xref ref-type="bibr" rid="bib95">Syrovatkina et al., 2016</xref>).</p><p>Many aspects of GPCR pharmacology remain elusive: e.g., the structural determinants of the selectivity displayed toward specific G proteins or the ability of certain agonists to drive a preferred intracellular signaling pathway over others (i.e. functional selectivity or bias) (<xref ref-type="bibr" rid="bib96">Tan et al., 2018</xref>). GPCRs are challenging proteins to characterize experimentally due to their inherent flexibility and the transitory nature of the complexes formed with extracellular and intracellular effectors. Importantly, agonists can allosterically modify the receptor selectivity profile by imprinting unique intracellular conformations from the orthosteric binding site. The mechanism behind these phenomena is one of the outstanding questions in the GPCR field (<xref ref-type="bibr" rid="bib39">Flock et al., 2017</xref>).</p><p>Molecular dynamics (MD) is a powerful computational methodology that predicts the movement and interactions of (bio)molecules in systems of variable complexity, at atomic detail. However, classic MD sampling is limited to the microsecond or, in the best conditions, the millisecond time scale (<xref ref-type="bibr" rid="bib50">Hollingsworth and Dror, 2018</xref>; <xref ref-type="bibr" rid="bib33">Durrant and McCammon, 2011</xref>). For this reason, different algorithms have been designed to speed up the simulation of rare events such as ligand (un)binding and conformational transitions. Among the most popular and effective ones are metadynamics (<xref ref-type="bibr" rid="bib12">Bussi and Laio, 2020</xref>) and path collective variables metadynamics (<xref ref-type="bibr" rid="bib19">D’Amore et al., 2024</xref>), accelerated MD (aMD) (<xref ref-type="bibr" rid="bib48">Hamelberg et al., 2004</xref>), and Gaussian-accelerated MD (GaMD) (<xref ref-type="bibr" rid="bib75">Miao et al., 2015</xref>), which introduce an energy potential to overcome the energy barriers preventing the complete exploration of the free energy surface, thus de facto bias the simulation. Energetically unbiased MD protocols, on the other hand, comprise weighted ensemble MD (<xref ref-type="bibr" rid="bib112">Zuckerman and Chong, 2017</xref>), swarms approach (<xref ref-type="bibr" rid="bib37">Fleetwood et al., 2020</xref>), AdaptiveGoal (<xref ref-type="bibr" rid="bib69">Lovera et al., 2019</xref>), and SuMD (<xref ref-type="bibr" rid="bib18">Cuzzolin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Sabbadin and Moro, 2014</xref>), which have largely been applied to (unbinding) small molecules, peptides, and small proteins (<xref ref-type="bibr" rid="bib18">Cuzzolin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Sabbadin and Moro, 2014</xref>; <xref ref-type="bibr" rid="bib24">Deganutti et al., 2021a</xref>; <xref ref-type="bibr" rid="bib30">Dong et al., 2020</xref>; <xref ref-type="bibr" rid="bib26">Deganutti et al., 2021c</xref>; <xref ref-type="bibr" rid="bib13">Cary et al., 2022</xref>). Since SuMD is optimized for (un)bindings, we have designed mwSuMD to address more complex conformational transitions and protein-protein associations. GPCRs preferentially couple to very few G proteins out of 23 possible counterparts (<xref ref-type="bibr" rid="bib39">Flock et al., 2017</xref>; <xref ref-type="bibr" rid="bib99">Wall et al., 2022</xref>). It is increasingly accepted that dynamic and transient interactions determine whether the encounter between a GPCR and a G protein results in productive or unproductive coupling (<xref ref-type="bibr" rid="bib17">Culhane et al., 2022</xref>). MD simulations are considered a useful orthogonal tool for providing working hypotheses and rationalizing existing data on G protein selectivity. However, so far, it has not delivered as expected. Attempts have usually employed energetically biased simulations, have been confined to the Gα subunit, or considered a preformed GPCR:G protein complex (<xref ref-type="bibr" rid="bib99">Wall et al., 2022</xref>; <xref ref-type="bibr" rid="bib72">Mattedi et al., 2020</xref>; <xref ref-type="bibr" rid="bib76">Miao and McCammon, 2018</xref>; <xref ref-type="bibr" rid="bib71">Mafi et al., 2023</xref>).</p><p>First, we validated mwSuMD on the nonapeptide arginine vasopressin (AVP) by simulating binding (dynamic docking) and unbinding paths from the vasopressin 2 receptor (V<sub>2</sub>R). Dynamic docking, although more computationally demanding than standard molecular docking, provides insights into the binding mode of ligands in a fully hydrated and flexible environment. Moreover, it informs about binding paths and the complete mechanism of formation leading to an intermolecular complex, delivering in the context of binding kinetics <xref ref-type="bibr" rid="bib46">Guo et al., 2017</xref> and structure-kinetics relationship studies (<xref ref-type="bibr" rid="bib45">Guo et al., 2015</xref>). We then studied the class B1 GPCR glucagon-like peptide-1 receptor (GLP-1R) activation by the small molecule PF06882961. GLP-1R is a validated target in type 2 diabetes and probably the best-characterized class B1 GPCR from a structural perspective. GLP-1R is the only class B1 receptor with structurally characterized non-peptidic orthosteric agonists, which makes it a model system for studying the druggability of the entire B1 subfamily. After GLP-1R agonist binding and activation, the coupling of G<sub>s</sub> and the release of guanosine diphosphate (GDP), the rate-limiting step of the G protein activation, was simulated for the first time using an energy-unbiased method.</p><p>These results demonstrate the usefulness of mwSuMD for illuminating the molecular events involved in GPCR function.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Short mwSuMD time windows improve the AVP dynamic docking prediction</title><p>AVP is an endogenous hormone (<xref ref-type="fig" rid="fig1">Figure 1a</xref>) that mediates antidiuretic effects on the kidney by signaling through three class A GPCR subtypes: V<sub>1a</sub> and V<sub>1b</sub> receptors activate phospholipases via G<sub>q/11</sub>, while the V<sub>2</sub>R activates adenylyl cyclase by interacting with G<sub>s</sub> (<xref ref-type="bibr" rid="bib9">Birnbaumer, 2000</xref>) and is a therapeutic target for hyponatremia, hypertension, and incontinence (<xref ref-type="bibr" rid="bib3">Ball, 2007</xref>). AVP is amphipathic and in the bound state interacts with both polar and hydrophobic V<sub>2</sub>R residues located on TM helices and ECLs (<xref ref-type="fig" rid="fig1">Figure 1b</xref>). Although AVP presents an intramolecular C1-C6 disulfide bond that limits the backbone’s overall conformational flexibility, it has many rotatable bonds, making dynamic docking complicated (<xref ref-type="bibr" rid="bib41">Gioia et al., 2017</xref>). We compared the performance of mwSuMD to the parent algorithm SuMD in reconstructing the experimental V<sub>2</sub>R:AVP complex using different settings, simulating a total of 92 binding events (<xref ref-type="table" rid="table1">Table 1</xref>). As a reference, the AVP root mean square deviation (RMSD) during a classic (unsupervised) equilibrium MD simulation of the X-ray AVP:V<sub>2</sub>R complex was 3.80±0.52 Å (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). SuMD (<xref ref-type="bibr" rid="bib18">Cuzzolin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Sabbadin and Moro, 2014</xref>) produced a minimum RMSD to the cryo-EM complex of 4.28 Å, with most of the replicas (i.e. distribution’s mode) having an RMSD close to 10 Å (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2a</xref>). mwSuMD, with the same settings (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2b</xref>, <xref ref-type="table" rid="table1">Table 1</xref>) in terms of time window duration (600 ps), metric supervised (the distance between AVP and V<sub>2</sub>R), and acceptance method (slope) produced slightly more precise results (i.e. distribution’s mode RMSD = 7.90 Å) but similar accuracy (minimum RMSD = 4.60 Å). Supervising the AVP RMSD to the experimental complex rather than the distance (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2c</xref>) and using the SMscore (<xref ref-type="disp-formula" rid="equ1">Equation 1</xref>) as the acceptance method (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2d</xref>) worsened the prediction. Supervising distance and RMSD at the same time (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2e</xref>), employing the DMscore (<xref ref-type="disp-formula" rid="equ2">Equation 2</xref>), recovered accuracy (minimum RMSD = 4.60 Å) but not precision (distribution mode RMSD = 12.40 Å). Interestingly, decreasing the time window duration from 600 ps to 100 ps impaired the SuMD ability to predict the experimental complex (<xref ref-type="fig" rid="fig1">Figure 1a</xref>), but enhanced mwSuMD accuracy and precision (<xref ref-type="fig" rid="fig1">Figure 1b–d</xref>). The combination of RMSD as the supervised metric and SMscore produced the best results in terms of minimum RMSD and distribution mode RMSD, 3.85 Å and 4.40 Å, respectively (<xref ref-type="fig" rid="fig1">Figure 1d</xref>, <xref ref-type="video" rid="video1">Video 1</xref>), in agreement with the AVP deviations in the equilibrium MD simulation of the X-ray AVP:V<sub>2</sub>R complex (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). These results confirm the inherent complexity of reproducing the AVP:V<sub>2</sub>R complex via dynamic docking and suggest that short time windows can improve mwSuMD performance on this system. However, it is necessary to know the final bound state to employ the RMSD as the supervised metric, while the distance is required to dynamically dock ligands with unknown bound conformation as previously reported (<xref ref-type="bibr" rid="bib18">Cuzzolin et al., 2016</xref>; <xref ref-type="bibr" rid="bib99">Wall et al., 2022</xref>). Both distance and RMSD-based simulations delivered insights into the binding path and the residues involved along the recognition route. For example, mwSuMD pinpointed V<sub>2</sub>R residues E184<sup>ECL2</sup>, P298<sup>ECL3</sup>, and E303<sup>ECL3</sup> (<xref ref-type="fig" rid="fig2">Figure 2a</xref>) as involved during AVP binding, although not in contact with the ligand in the orthosteric complex. None of them are yet characterized through mutagenesis studies according to the GPCRdb (<xref ref-type="bibr" rid="bib55">Isberg et al., 2016</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Arginine vasopressin (AVP) supervised molecular dynamics (SuMD) and multiple walker SuMD (mwSuMD) binding simulations to vasopressin 2 receptor (V<sub>2</sub>R) (100 ps time windows).</title><p>(<bold>a</bold>) Chemical structure and (<bold>b</bold>) binding more within the V<sub>2</sub>R orthosteric binding site; AVP is represented in orange stick, while V<sub>2</sub>R is in white ribbon and gray stick. For each set of settings (<bold>c–f</bold>) the root mean square deviation (RMSD) of AVP Cα atoms to the cryo-electron microscopy (cryo-EM) structure 7DW9 is reported during the time course of each SuMD (<bold>c</bold>) or mwSuMD (<bold>d–f</bold>) replica alongside the RMSD values distribution and the snapshot corresponding to the lowest RMSD values (AVP from the cryo-EM structure 7DW9 is in a cyan stick representation, while AVP from simulations is in a tan stick representation). A complete description of the simulation settings is reported in <xref ref-type="table" rid="table1">Table 1</xref> and the Methods section. The dashed red line indicates the AVP RMSD during a classic (unsupervised) equilibrium MD simulation of the X-ray AVP:V<sub>2</sub>R complex (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Classic molecular dynamics (MD) simulation of the AVP:V<sub>2</sub>R complex (PDB ID 7DW9).</title><p>The average AVP root mean square deviation (RMSD) (computed on the Cα atoms) after stabilization of the system (second half of the trajectory) is indicated. AVP, arginine vasopressin; V<sub>2</sub>R, vasopressin 2 receptor.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Arginine vasopressin (AVP) supervised molecular dynamics (SuMD) and multiple walker SuMD (mwSuMD) binding simulations to vasopressin 2 receptor (V<sub>2</sub>R) (600 ps time windows).</title><p>For each set of settings (<bold>a</bold>-<bold>e</bold>), the RMSD of AVP Cα atoms to the cryo-EM structure 7DW9 is reported during the time course of each SuMD (<bold>a</bold>) or mwSuMD (<bold>b</bold>-<bold>e</bold>) replica, alongside the RMSD values distribution and the snapshot corresponding to the lowest RMSD (AVP from the cryo EM structure 7DW9 is in a cyan stick representation, while AVP from simulations is in a tan stick representation). A complete description of the simulation settings is reported in <xref ref-type="table" rid="table1">Table 1</xref> and the Methods section. The dashed red line indicates the AVP RMSD during a classic (unsupervised) equilibrium MD simulation of the X-ray AVP:V2R complex (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig1-figsupp2-v1.tif"/></fig></fig-group><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Summary of all the simulations performed and the settings employed.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">System</th><th align="left" valign="bottom"># Replicas</th><th align="left" valign="bottom">TWduration</th><th align="left" valign="bottom"># Walkers</th><th align="left" valign="bottom">Metric</th><th align="left" valign="bottom">Acceptance</th></tr></thead><tbody><tr><td align="left" valign="bottom">V<sub>2</sub>R:AVP<break/>complex</td><td align="left" valign="bottom">1 classic MD</td><td align="left" valign="bottom">500 ns</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">N/A</td></tr><tr><td align="left" valign="bottom" rowspan="9">V<sub>2</sub>R:AVP<break/>binding</td><td align="left" valign="bottom">9 (SuMD)</td><td align="left" valign="bottom">600 ps</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">Slope</td></tr><tr><td align="left" valign="bottom">10 (mwSuMD)</td><td align="left" valign="bottom">600 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">Slope</td></tr><tr><td align="left" valign="bottom">11 (mwSuMD)</td><td align="left" valign="bottom">600 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">RMSD</td><td align="left" valign="bottom">Slope</td></tr><tr><td align="left" valign="bottom">8 (mwSuMD)</td><td align="left" valign="bottom">600 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">SMscore</td></tr><tr><td align="left" valign="bottom">9 (mwSuMD)</td><td align="left" valign="bottom">600 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Distance and RMSD</td><td align="left" valign="bottom">DMscore</td></tr><tr><td align="left" valign="bottom">12 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Distance and RMSD</td><td align="left" valign="bottom">DMscore</td></tr><tr><td align="left" valign="bottom">11 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">SMscore</td></tr><tr><td align="left" valign="bottom">11 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">RMSD</td><td align="left" valign="bottom">SMscore</td></tr><tr><td align="left" valign="bottom">10 (SuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">Slope</td></tr><tr><td align="left" valign="bottom" rowspan="2">V<sub>2</sub>R:AVP<break/>unbinding</td><td align="left" valign="bottom">5 (SuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">N/A</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">Slope</td></tr><tr><td align="left" valign="bottom">5 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">10</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">SMscore</td></tr><tr><td align="left" valign="bottom">β<sub>2</sub> AR:G<sub>s</sub> protein<break/>binding</td><td align="left" valign="bottom">3 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Distance and RMSD</td><td align="left" valign="bottom">DMscore</td></tr><tr><td align="left" valign="bottom">A1R:G<sub>i</sub> binding</td><td align="left" valign="bottom">1 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">RMSD</td><td align="left" valign="bottom">SMscore</td></tr><tr><td align="left" valign="bottom">GLP-1R:PF06882961</td><td align="left" valign="bottom">1 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Distance or RMSD (or a combination)</td><td align="left" valign="bottom">SMscore<break/>or DMscore</td></tr><tr><td align="left" valign="bottom">GLP-1R:G<sub>s</sub> protein binding</td><td align="left" valign="bottom">3 (mwSuMD)</td><td align="left" valign="bottom">200 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Distance or RMSD</td><td align="left" valign="bottom">SMscore<break/>or DMscore</td></tr><tr><td align="left" valign="bottom">G<sub>s</sub> AHD opening</td><td align="left" valign="bottom">1 (mwSuMD)</td><td align="left" valign="bottom">100 ps</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">SMscore</td></tr><tr><td align="left" valign="bottom">GLP-1R:G<sub>s</sub><break/>GDP unbinding</td><td align="left" valign="bottom">3</td><td align="left" valign="bottom">50 ps</td><td align="left" valign="bottom">5</td><td align="left" valign="bottom">Distance</td><td align="left" valign="bottom">SMscore</td></tr></tbody></table><table-wrap-foot><fn><p>N/A: not applicable; SuMD was not performed.</p></fn></table-wrap-foot></table-wrap><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Multiple walker supervised molecular dynamics (mwSuMD) (un)binding simulations of arginine vasopressin (AVP).</title><p>Vasopressin 2 receptor (V<sub>2</sub>R) residues involved in mwSuMD simulations of AVP. (<bold>a</bold>) Binding (dynamic docking); (<bold>b</bold>) unbinding simulations. (<bold>c</bold>) Dissociation of AVP from V<sub>2</sub>R. The root mean square deviation (RMSD) of AVP to the initial bound state is reported during the time course of five replicas of SuMD and mwSuMD, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig2-v1.tif"/></fig><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video1.mp4" id="video1"><label>Video 1.</label><caption><title>Arginine vasopressin (AVP) binding (dynamic docking) to vasopressin 2 receptor (V<sub>2</sub>R).</title><p>Two-view of the mwSuMD replica better reproducing the AVP:V2R experimental complex. Left side: V2R is represented in white quick surface, while AVP is in transparent quick surface and green stick; right side: V2R is represented in white ribbon and cyan stick, while AVP is a green stick. The bound AVP conformation from PDB 7DW9 is reported as a reference in transparent orange ribbon and stick.</p></caption></media><p>Further to binding, an SuMD approach was previously employed to reconstruct the unbinding path of ligands from several GPCRs (<xref ref-type="bibr" rid="bib23">Deganutti et al., 2020b</xref>; <xref ref-type="bibr" rid="bib2">Atanasio et al., 2020</xref>). We assessed mwSuMD’s capability to simulate AVP unbinding from V<sub>2</sub>R. Five mwSuMD and five SuMD replicas were collected using 100 ps time windows (<xref ref-type="table" rid="table1">Table 1</xref>). Overall, mwSuMD outperformed SuMD in terms of time required to complete a dissociation (<xref ref-type="fig" rid="fig2">Figure 2c</xref>, <xref ref-type="video" rid="video2">Video 2</xref>), producing dissociation paths almost 10 times faster than SuMD. Such rapidity in dissociating inherently produces a limited sampling of metastable states along the pathway, which can be compensated by seeding classic (unsupervised) MD simulations from configurations extracted from the unbinding pathway (<xref ref-type="bibr" rid="bib25">Deganutti et al., 2021b</xref>; <xref ref-type="bibr" rid="bib22">Deganutti et al., 2020a</xref>). Here, the V<sub>2</sub>R residues involved during the dissociation were comparable to the binding (<xref ref-type="fig" rid="fig2">Figure 2a and b</xref>), although ECL2 and ECL3 were slightly more involved during the association than the dissociation, in analogy with other class A and B GPCRs (<xref ref-type="bibr" rid="bib30">Dong et al., 2020</xref>; <xref ref-type="bibr" rid="bib25">Deganutti et al., 2021b</xref>).</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video2.mp4" id="video2"><label>Video 2.</label><caption><title>Arginine vasopressin (AVP) unbinding from vasopressin 2 receptor (V<sub>2</sub>R).</title><p>Two-view of the five mwSuMD replicas performed. Left side: V2R is represented in white quick surface, while AVP is in transparent quick surface and green stick; right side: V2R is represented in white ribbon and cyan stick, while AVP is a green stick.</p></caption></media></sec><sec id="s2-2"><title>PF06882961 binding and GLP-1R activation</title><p>The GLP-1R has been captured by cryo-EM in both the inactive and the active (G<sub>s</sub>-bound) conformations and in complex with either peptide or non-peptide agonists (<xref ref-type="bibr" rid="bib110">Zhao et al., 2020</xref>; <xref ref-type="bibr" rid="bib59">Kawai et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Ma et al., 2020</xref>; <xref ref-type="bibr" rid="bib108">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="bib14">Cong et al., 2021</xref>; <xref ref-type="bibr" rid="bib16">Cong et al., 2022b</xref>). In the inactive GLP-1R, residues forming the binding site for the non-peptide agonist PF06882961 are dislocated and scattered due to the structural reorganization of the transmembrane domain (TMD) and ECD (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1a</xref>) that occurs on activation. Moreover, GLP-1R in complex with GLP-1 or different agonists present distinct structural features, even among structurally related ligands (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1b and c</xref>). This complicates the scenario and suggests divergent recognition mechanisms among different agonists. We simulated the binding of PF06882961, reaching an RMSD to its bound conformation in 7LCJ of 3.79±0.83 Å (computed on the second half of the merged trajectory, superimposing on GLP-1R Cα atoms of TMD residues 150–390), using multistep supervision on different system metrics (<xref ref-type="fig" rid="fig3">Figure 3</xref>) to model the structural hallmark of GLP-1R activation (<xref ref-type="video" rid="video3">Videos 3</xref> and <xref ref-type="video" rid="video4">4</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Multiple walker supervised molecular dynamics (mwSuMD) simulation of PF06882961 binding to glucagon-like peptide-1 receptor (GLP-1R) and receptor activation.</title><p>Each panel reports the root mean square deviation (RMSD) to the position of the ligand in the active state (top panel) or a GLP-1R structural element over the time course (all but ECL3 converging to the active state). ECD: extracellular domain; TM: transmembrane helix; ECL: extracellular loop. The mwSuMD simulation was performed with four different settings over 1 µs in total. The red dashed lines show the initial RMSD value for reference.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Multiple walker supervised molecular dynamics (mwSuMD) simulation of PF06882961, glucagon-like peptide-1 receptor (GLP-1R) activation, and guanosine diphosphate (GDP) release.</title><p>(<bold>a</bold>) PF06882961 binding site in the apo and holo GLP-1R. In the apo GLP-1R (left transparent ribbon) the residues forming the binding site of the NPA PF06882961 are scattered due to the different conformation of the receptor. (<bold>b, c</bold>) NPAs stabilize divergent GLP-1R active conformations: (<bold>a</bold>) Different orientations of TM2, ECL1, and TM3; (<bold>b</bold>) divergent conformations of extracellular domain (ECD), ECL3, and TM7; (<bold>c</bold>) interaction fingerprint of NPAs (TT-OAD2, CHU-128, and PF06882911) and the endogenous agonist peptide GLP-1. Red bars indicate interactions with distinct residues in the GLP-1R.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig3-figsupp1-v1.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Dynamic feautures of GLP-1R activation and Gs binding.</title><p>(<bold>a</bold>) Rotation of TM6 during glucagon-like peptide-1 receptor (GLP-1R) activation simulated by multiple walker supervised molecular dynamics (mwSuMD). The angle was measured as the dihedral formed by the backbone alpha carbon atoms T353, I357, T362, and I366. The angle values of the inactive and active cryo-electron microscopy (cryo-EM) structures are reported as references; (<bold>b</bold>) PF06882961 MM-GBSA binding energy during G<sub>s</sub> binding; (<bold>d</bold>) guanosine diphosphate (GDP) MM-GBSA binding energy during G<sub>s</sub> binding.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig3-figsupp2-v1.tif"/></fig></fig-group><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video3.mp4" id="video3"><label>Video 3.</label><caption><title>Morph of the PF06882961 binding and glucagon-like peptide-1 receptor (GLP-1R) activation.</title><p>The first and last frames of the PF06882961 binding simulations have been interpolated to produce a smoothed representative transition.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video4.mp4" id="video4"><label>Video 4.</label><caption><title>PF06882961 binding and glucagon-like peptide-1 receptor (GLP-1R) activation.</title><p>PF06882961 is represented in cyan van der Waals spheres, while GLP-1R is orange ribbon; the GLP-1R experimental active conformation is reported in transparent green ribbon as reference.</p></caption></media><p>Several metrics were supervised consecutively. First, the distance between PF06882961 and the TMD as well as the RMSD of the ECD to the active state (stage 1); second, the RMSD of ECD and ECL1 to the active state (stage 2); third, the RMSD of PF06882961 and ECL3 to the active state (stage 3); lastly, only the RMSD of TM6 (residues I345-F367, Cα atoms) to the active state (stage 4). The combination of these supervisions produced a conformational transition of GLP-1R toward the active state (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="video" rid="video4">Video 4</xref>). Noteworthy, mwSuMD, like any other CV-based technique, requires some knowledge of the simulated system. The sequence of these supervisions was arbitrary and does not necessarily reflect the right order of the steps involved in GLP-1R activation. This kind of planned multistep approach is feasible when the end-point receptor inactive and active structures are available, and the inherent flexibility of different domains is known. In class B GPCRs, the ECD is the most dynamic substructure, followed by the ECL1 and ECL3, which display high plasticity during ligand binding (<xref ref-type="bibr" rid="bib30">Dong et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Cong et al., 2022a</xref>). For this reason, we first supervised these elements of GLP-1R, leaving the bottleneck of activation, TM6 outward movement, as the last step. However, the protocol employed can be tweaked to study how each conformational transition takes place and influences the receptor domains. Structural elements not directly supervised, such as TM1 or TM7, were influenced by the movement of supervised helixes or loops and therefore displayed an RMSD reduction to the active state. For example, the supervision of ECL3 (stage 3) and TM6 (stage 4) facilitated the spontaneous rearrangement of the ECD to an active-like conformation after the ECD had previously experienced transient high flexibility during stages 2 and 3 (<xref ref-type="fig" rid="fig3">Figure 3</xref>). These results suggest a concerted conformational transition for ECD and ECL1 during the binding of PF06882961 and an allosteric effect between ECL3 and the bottom of TM6. While the intracellular polar interactions were destabilized by the ECL3 transition to an active-like conformation (stages 2 and 3), the outward movement of TM6 (stage 4) did not favor the closure of ECL3 toward PF06882961, which appears to be driven by direct interactions between the ligand and R310<sup>5.40</sup> or R380<sup>7.35</sup>. Interestingly, the mwSuMD simulation during stage 4 (TM6 supervision) sampled a counterclockwise helix rotation (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2a</xref>) consistent with the GLP-1R cryo-EM structures in the active, G<sub>s</sub>-coupled state (<xref ref-type="bibr" rid="bib108">Zhang et al., 2020</xref>; <xref ref-type="bibr" rid="bib109">Zhang et al., 2021</xref>).</p><p>It is worth noting that 6LN2, the only inactive GLP-1R structure available complete with the ECD, was stabilized and solved with an antibody bound to the ECD. This strategy might have forced the ECD into a closed conformation that engages the EC <italic>vestibule</italic> of GLP-1R and possibly restrained the whole TMD in an altered conformation that deviates from the physiological conditions. This might explain why the RMSD of the TMD elements monitored during the simulation rarely reach values lower than 3 Å or 4 Å.</p><p>During the supervision of ECL3 and PF06882961 (stage 3), we observed a loosening of the intracellular polar interactions that stabilize GLP-1R TM6 in the inactive state. As a result, the subsequent supervision of TM6 (residues I345-F367, Cα atoms) rapidly produced the outward movement of TM6 toward the active state, in the last step of the mwSuMD simulation (stage 4). A more detailed analysis revealed that the central polar network, which is pivotal for mediating GLP-1 signaling (<xref ref-type="bibr" rid="bib103">Wootten et al., 2016</xref>), and the residues at the TM6 kink level adopted active-like conformations during the final stage of the simulation (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). In particular, the central polar network (E364<sup>6.53</sup>, H363<sup>6.52</sup>, and Q394<sup>7.49</sup>) experienced side chain rearrangements (<xref ref-type="fig" rid="fig4">Figure 4b</xref>) while extensive TM6 kink dislocation occurred at L360<sup>6.49</sup>, P358<sup>6.48</sup>, L357<sup>6.47</sup>, and I357<sup>6.46</sup> (<xref ref-type="fig" rid="fig4">Figure 4c</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Glucagon-like peptide-1 receptor (GLP-1R) key structural motifs during multiple walker supervised molecular dynamics (mwSuMD) GLP-1R activation.</title><p>(<bold>a</bold>) Root mean square deviation (RMSD) to the active state GLP-1R (7LCI) of the residues forming the central polar network (magenta) and TM6 kink (orange) during mwSuMD of receptor activation; at the end of the simulations minimum values were reached (dashed square). (<bold>b</bold>) The position of the polar network within the core of transmembrane domain (TMD) (left-hand panel) and comparison between inactive, active, and mwSuMD final states for the side chains of the residues forming of the polar network. (<bold>c</bold>) The position of the TM6 kink (right-hand panel) and comparison between inactive, active, and mwSuMD final states for the side chains of the residues forming the TM6 kink.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig4-v1.tif"/></fig></sec><sec id="s2-3"><title>G<sub>s</sub> protein binding to GLP-1R and GDP release</title><p>We then focused on simulating the G<sub>s</sub> binding to GLP-1R, after activation, <italic>without energy input</italic>. For this purpose, we first tested the binding between the prototypical class A receptor β<sub>2</sub> adrenoreceptor (β<sub>2</sub> AR) and the stimulatory G protein (G<sub>s</sub>) (<xref ref-type="video" rid="video5">Video 5</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1a and b</xref>) by supervising the distance between G<sub>s</sub> helix 5 (α5) and β<sub>2</sub> AR as well as the RMSD of the intracellular end of TM6 to the fully active state of the receptor (see Supplementary Methods). During two out of three replicas, both Gα and Gβ achieved distance values close to 5 Å (minimum RMSD = 3.94 Å and 3.96 Å respectively), in good agreement with the reference (the β<sub>2</sub> AR:G<sub>s</sub> complex, PDB 3SN6, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1c</xref>). A possible pitfall is that G proteins bear potential palmitoylation and myristoylation sites that anchor the inactive trimer to the plasma membrane (<xref ref-type="bibr" rid="bib65">Linder et al., 1993</xref>; <xref ref-type="bibr" rid="bib107">Zhang et al., 2004</xref>), de facto restraining possible binding paths to the receptor. To address this point and test different conditions, we prepared the adenosine A1 receptor (A<sub>1</sub>R) and its principal effector, the inhibitory G protein (G<sub>i</sub>) considering the G<sub>i</sub>α residue C3 and Gγ residue C65 as palmitoylated and geranylgeranylated respectively and hence inserted in the membrane. Recently, the G<sub>i</sub> binding to A<sub>1</sub>R was simulated by combining the biased methods GaMD with SuMD (<xref ref-type="bibr" rid="bib63">Li et al., 2022</xref>) but without considering membrane-anchoring posttranslational modifications. Both classic (unsupervised) and mwSuMD simulations were performed on this system for comparison (<xref ref-type="video" rid="video6">Video 6</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1d</xref>). In about 50 ns of mwSuMD, the G<sub>i</sub>α subunit engaged its intracellular binding site on A<sub>1</sub>R and formed a complex in good agreement with the cryo-EM structure (PDB 6D9H, RMSD ≈ 5 Å). For comparison, 1 μs of cMD did not produce a productive engagement as the G<sub>i</sub>α remained at RMSD values &gt;40 Å (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1d</xref>), suggesting the effectiveness of mwSuMD in sampling G protein binding rare events without the input of energy. The membrane anchoring affected the overall G<sub>i</sub> binding and the final complex, which was rotated compared to the experimental structure due to the lipidation of G<sub>i</sub>α and Gγ (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1e</xref>).</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video5.mp4" id="video5"><label>Video 5.</label><caption><title>G<sub>s</sub> binding to β<sub>2</sub> adrenoreceptor (β<sub>2</sub> AR).</title><p>The inactive G<sub>s</sub> (G<sub>α</sub> subunit in orange, G<sub>β</sub> subunit in green, and G<sub>γ</sub> subunit in yellow) recognizes β<sub>2</sub>AR (black ribbon) bound to epinephrine (van der Waals spheres). The experimental β<sub>2</sub>AR:G<sub>s</sub> cryo-EM complex is reported in white ribbon for reference.</p></caption></media><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video6.mp4" id="video6"><label>Video 6.</label><caption><title>G<sub>i</sub> binding to A1 receptor (A<sub>1</sub>R).</title><p>The G<sub>i</sub> (G<sub>α</sub> subunit in magenta, G<sub>β</sub> subunit in green, and G<sub>γ</sub> subunit in yellow) recognizes A<sub>1</sub>R (blue ribbon) bound to adenosine (not shown). The experimental A<sub>1</sub>R:G<sub>i</sub> cryo-EM complex is reported in transparent ribbon for reference.</p></caption></media><p>Encouraged by results obtained on G<sub>s</sub> and G<sub>i</sub> binding to β<sub>2</sub> AR and A<sub>1</sub>R (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), we extracted the GLP-1R active conformation described above and simulated the G<sub>s</sub> binding to its intracellular side. Starting from the inactive, membrane-anchored G<sub>s</sub>, we performed three independent mwSuMD replicas by supervising the distance between G<sub>s</sub> helix α5 and GLP-1R residues located at the intracellular binding interface (<xref ref-type="fig" rid="fig5">Figure 5a and e</xref>). All three mwSuMD replicas showed the G<sub>s</sub> approaching GLP-1R, with two out of three reaching an RMSD of the G<sub>s</sub>α subunit close to or less than 10 Å, compared to the experimental complex 7LCI (<xref ref-type="fig" rid="fig5">Figure 5e</xref>). Replica 2, in particular, reproduced the cryo-EM GLP-1R:G<sub>s</sub> complex with RMSD values to 7LCI of 7.59±1.58 Å, 12.15±2.13 Å, and 13.73±2.24 Å for Gα, Gβ, and Gγ, respectively. Such values do not support convergence with the static experimental structure but are not far from the RMSDs measured in our previous simulations of GLP-1R in complex with G<sub>s</sub> and GLP-1 (<xref ref-type="bibr" rid="bib27">Deganutti et al., 2022</xref>) (Gα=6.18 ± 2.40 Å; Gβ=7.22 ± 3.12 Å; Gγ=9.30 ± 3.65 Å), which indicates overall higher flexibility of Gβ and Gγ compared to Gα, which acts as a sort of fulcrum bound to GLP-1R.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Glucagon-like peptide-1 receptor (GLP-1R) activation and G<sub>s</sub> binding.</title><p>(<bold>a–d</bold>) Sequence of simulated events during the multiple walker supervised molecular dynamics (mwSuMD) G<sub>s</sub>:GLP-1R simulations. (<bold>e</bold>) Root mean square deviation (RMSD) of G<sub>s</sub>α to the experimental GLP-1R:G<sub>s</sub> complex (PDB 7LCJ) during three mwSuMD replicas; the RMSD to the experiential bound conformation (7LCJ) during the second part of Replica 2 (red dashed line) is reported for each G<sub>s</sub> subunit. RMSDs were computed on Gα residues 11–43 and 205–394 to the experimental structure 7LCI after superimposition on GLP-1R residues 140–240 Cα atoms. (<bold>f</bold>) RMSD of the αG-α4 loop (purple), the distance between K342<sup>6.31</sup> and D323<sup>Gα</sup> (salmon), and the distance between guanosine diphosphate (GDP) and D295<sup>Gα</sup> (green) during G<sub>s</sub> binding, alpha-helical domain (AHD) opening and GDP dissociation; (<bold>g</bold>) and (<bold>h</bold>) comparison between states extracted from before and after AHD opening. Before AHD opening (<bold>a</bold>), GLP-1R ICL3 interacted with D323<sup>Gα</sup> and D295<sup>Gα</sup> interacted with GDP; after AHD opening (<bold>b</bold>) and αG-α4 loop reorganization (curved red arrow), αG and D295<sup>Gα</sup> moved away from GDP (straight red arrow), destabilizing its binding to G<sub>s</sub>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>G protein binding simulations to β<sub>2</sub> adrenoreceptor (β<sub>2</sub> AR) and A1 receptor (A<sub>1</sub>R).</title><p>(<bold>a</bold>) Root mean square deviation (RMSD) of G<sub>s</sub>α to the experimental complex (PDB 3NS6) during three multiple walker supervised molecular dynamics (mwSuMD) replicas; (<bold>b</bold>) RMSD of G<sub>s</sub>β to the experimental complex (PDB 3NS6) during three mwSuMD replicas; (<bold>c</bold>) superposition of the experimental G<sub>s</sub>:β<sub>2</sub> AR complex (transparent ribbon) and the MD frame with the lowest G<sub>s</sub>α RMSD (3.94 Å); (<bold>d</bold>) RMSD of G<sub>i</sub>α (residues 243–355) to the A<sub>1</sub>R experimental complex (PDB 6D9H) during an mwSuMD simulation (red, magnified in the box) and a 1000-ns-long classic MD simulation (black); (<bold>e</bold>) two-view superposition of the experimental G<sub>i</sub>:A<sub>1</sub>R complex (transparent ribbon) and the MD frame with the lowest G<sub>i</sub>α RMSD (4.82 Å).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Comparison of the inactive (6EG8, white), nucleotide-free (7LCI, black), and guanosine diphosphate (GDP)-dissociated (multiple walker supervised molecular dynamics [mwSuMD] simulation, green) β6-α5 loop.</title><p>Bound (white, 6EG8) and dissociated (green, mwSuMD) GDP is shown as a stick representation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig5-figsupp2-v1.tif"/></fig></fig-group><p>According to the model of G protein activation, the G protein binding has the effect of allosterically stabilizing the orthosteric agonist in complex with the receptor (<xref ref-type="bibr" rid="bib27">Deganutti et al., 2022</xref>) and destabilizing the GDP bound to Gα, triggering its release and exchange with guanosine triphosphate (<xref ref-type="bibr" rid="bib44">Gregorio et al., 2017</xref>), upon opening of the G protein alpha-helical domain (AHD). Following this model, PF06882961 and GDP were respectively stabilized and destabilized during the simulated G<sub>s</sub> association (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2b and c</xref>). The analysis of atomic contacts along the binding path of G<sub>s</sub> to GLP-1R highlights a few persistent interactions not observed in the equilibrium MD simulations of GLP-1R:G<sub>s</sub> cryo-EM complexes <xref ref-type="bibr" rid="bib27">Deganutti et al., 2022</xref>; e.g., we propose the hidden interaction between D344<sup>6.33</sup> and R385<sup>α5</sup> to be important for G<sub>s</sub> coupling (<xref ref-type="table" rid="app1table1">Appendix 1—table 1</xref>), which would explain the GLP-1 EC<sub>50</sub> reduction upon mutation of position 344 to Ala (<xref ref-type="bibr" rid="bib106">Yuan et al., 2023</xref>).</p><p>Extending Replica 2, we further investigated the G<sub>s</sub> activation mechanism by supervising the opening of the G<sub>s</sub> AHD, which is considered a necessary step to allow GDP release from the Ras-like domain (<xref ref-type="bibr" rid="bib31">Dror et al., 2015</xref>). We first easily obtained the opening of AHD (<xref ref-type="fig" rid="fig5">Figure 5b</xref>) and successively supervised the GDP unbinding in a further three replicas, seeded after the AHD opening. In one of these three mwSuMD simulations, the nucleotide dissociated from G<sub>s</sub> (<xref ref-type="fig" rid="fig5">Figure 5d</xref>). <xref ref-type="video" rid="video7">Video 7</xref> shows the full G<sub>s</sub> binding<bold>,</bold> AHD opening, and GDP release. mwSuMD suggested several structural changes as implicated in GDP dissociation (<xref ref-type="fig" rid="fig5">Figure 5f–h</xref>): (i) the AHD opening; (ii) the conformational change of αG-α4 loop (residues A303<sup>Gα</sup>-P332<sup>Gα</sup>), in concert with a loosening of interactions between D323<sup>Gα</sup> and K342<sup>6.31</sup>, and (iii) the rupture of the hydrogen bond between GDP and D295<sup>Gα</sup> triggered by the movement of αG away from the GDP binding site (<xref ref-type="fig" rid="fig5">Figure 5f</xref>). The involvement of αG through the αG-α4 during the release of GDP from G<sub>s</sub> is supported by hydrogen/deuterium exchange experiments (<xref ref-type="bibr" rid="bib32">Du et al., 2019</xref>), while the role of D275<sup>Gα</sup> has been probed with functional assays on the G<sub>i</sub> isoform mutant D272<sup>Gαi</sup>A (<xref ref-type="bibr" rid="bib47">Ham et al., 2021</xref>). Moreover, a similar αG behavior was recently suggested by MD simulations of the G<sub>s</sub> binding pathway to β<sub>2</sub> AR (<xref ref-type="bibr" rid="bib5">Batebi et al., 2024</xref>). We also note that the αG-α4 loop length and amino acidic composition diverge among G protein isoforms, further suggesting a role in G protein selectivity consistent with the hypothesis that, in different G proteins, distinct domains of the Gα subunit could be responsible for receptor selectivity (<xref ref-type="bibr" rid="bib42">Glukhova et al., 2018</xref>). However, a more subtle allosteric communication through internal structural elements like the β2-β3 strands, prompted by α5 tilting, could have weakened GDP phosphate binding as previously suggested by other groups (<xref ref-type="bibr" rid="bib94">Sun et al., 2018</xref>; <xref ref-type="bibr" rid="bib60">Kaya et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Flock et al., 2015</xref>). Interestingly, no significant conformational changes of the β6-α5 loop happened before or during the GDP dissociation, suggesting that its conformational change as captured in the nucleotide-free GLP-1R:G<sub>s</sub> complex (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>) occurs after the GDP release as a result of the loss of binding stabilization, rather than being an initiator of the GDP dissociation.</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-96513-video7.mp4" id="video7"><label>Video 7.</label><caption><title>G<sub>s</sub> binding to glucagon-like peptide-1 receptor (GLP-1R) and guanosine diphosphate (GDP) release.</title><p>The Gs protein binds GLP-1R (light grey) in complex with PF06882961 (stick representation) before the alpha-helical domain opens and allows GDP release from G<sub>sα</sub>. The G<sub>sα</sub> subunit is yellow, G<sub>β</sub> is dark gray, and G<sub>γ</sub> is orange.</p></caption></media></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Classic MD simulations sample phase space with an efficiency that depends on the energy barrier between neighboring minima. Processes like (un)binding and protein activation require the system to overcome numerous energy barriers, some creating bottlenecks that slow the transition down to the millisecond, or second, time scale. To reduce some of these limits, we have developed and tested on complex structural events characterizing GPCRs, an energetically unbiased adaptive sampling algorithm, namely mwSuMD, which is based on traditional SuMD, while drawing on parallel multiple replica methods (<xref ref-type="bibr" rid="bib28">Dickson and Brooks, 2014</xref>; <xref ref-type="bibr" rid="bib93">Sugita and Okamoto, 1999</xref>).</p><p>Our simulations propose that remarkable predictivity can be obtained with distance-driven mwSuMD, as demonstrated by the lowest deviation from the experimental AVP:V<sub>2</sub>R complex. The dissociation of AVP from V<sub>2</sub>R was simulated much more rapidly by mwSuMD than by SuMD, suggesting it is an efficient tool for studying the dissociation of ligands from GPCRs. This is due to the more extensive sampling obtainable by seeding multiple parallel short simulations instead of a single simulation for batch.</p><p>mwSuMD performed similarly to SuMD for the dynamic docking of AVP to V2R when time windows of 600 ps were employed. Time windows of 100 ps remarkably improved mwSuMD. Usually, dynamic docking is performed to either predict the geometry of complexes or sample the binding path of an already-known intermolecular complex, or both. The RMSD of AVP to the experimental coordinates as the supervised metric produced the best results. Consequently, the RMSD should be the metric of choice to study the binding path of well-known intermolecular complexes. The distance, on the other hand, is necessary when limited structural information about the binding mode is available. In the absence of structural information regarding the final bound state, it is possible to sample numerous binding events employing mwSuMD and evaluate the final bound states rank by applying end-point free energy binding methods like the molecular mechanics energies combined with the Poisson-Boltzmann or generalized Born and surface area continuum solvation (MM/PBSA and MM/GBSA [<xref ref-type="bibr" rid="bib100">Wang et al., 2019</xref>]) models.</p><p>We increased the complexity of binding simulations by considering GLP-1R and the non-peptide agonist PF06882961. Using mwSuMD, we obtained a binding of PF06882961 in good agreement with the cryo-EM structure, followed by an active-like conformational transition of GLP-1R. The choice of the metrics supervised was driven by the structural data available (<xref ref-type="bibr" rid="bib108">Zhang et al., 2020</xref>) and extensive preparatory MD simulations. However, binding routes are possible from either the bulk solvent or the membrane (<xref ref-type="bibr" rid="bib25">Deganutti et al., 2021b</xref>; <xref ref-type="bibr" rid="bib92">Stanley et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Bokoch et al., 2018</xref>). These results show the power of the mwSuMD method, indicating that future applications could include ligand binding from the membrane, or alternative apo receptor conformations to improve the sampling for more difficult receptors.</p><p>mwSuMD enabled us to simulate the G<sub>s</sub> binding to the active GLP-1R and the subsequent GDP release. Our results suggest a concerted effect on GDP binding produced by AHD opening, αG-α4 loop rearrangement, and αG shift away from the GDP site. The full rotation and elongation of α5 as in cryo-EM structures would occur after the GDP release, supporting the role of hidden, metastable interactions as the driving force of G protein coupling and selectivity, as per recent work on GLP-1R (<xref ref-type="bibr" rid="bib106">Yuan et al., 2023</xref>).</p><p>We stress that a complete understanding of a complex molecular event like G protein coupling requires the collection of numerous G protein binding paths and GDP dissociation events. mwSuMD is designed to yield a mechanistic description of structural events. For this reason, it integrates well with mutagenesis and kinetics experiments. We note that mwSuMD trajectories, since they describe the sequential states along a transition pathway, can represent a precious backbone for further MD sampling aimed at quantifying or predicting the kinetics of the transition. Approaches such as path collective variable metadynamics (<xref ref-type="bibr" rid="bib1">Alba Ortíz et al., 2019</xref>), Markov state models (<xref ref-type="bibr" rid="bib54">Husic and Pande, 2018</xref>), or machine learning models (<xref ref-type="bibr" rid="bib61">Kokh et al., 2019</xref>; <xref ref-type="bibr" rid="bib81">Pérez et al., 2018</xref>) can be informed by mwSuMD. We will address these novel opportunities created by mwSuMD in future work.</p><p>In summary, we showcased the applicability domain of mwSuMD to key, but scarcely understood, aspects of GPCR structural biology, pharmacology, and drug design hitherto unaddressed by unbiased simulations. Given the generality and simplicity of its implementation, we anticipate that mwSuMD can be employed to study a wide range of structural phenomena characterizing both membrane and cytosolic proteins. mwSuMD is an ongoing project updated on <ext-link ext-link-type="uri" xlink:href="https://github.com/pipitoludovico/mwSuMD_multiEngine">https://github.com/pipitoludovico/mwSuMD_multiEngine</ext-link> (copy archived at <xref ref-type="bibr" rid="bib84">Pipitò, 2025</xref>) and, in the recent implementation, can exploit ACEMD (<xref ref-type="bibr" rid="bib49">Harvey et al., 2009</xref>), NAMD (<xref ref-type="bibr" rid="bib83">Phillips et al., 2005</xref>), GROMACS (<xref ref-type="bibr" rid="bib7">Berendsen et al., 1995</xref>), and OPENMM (<xref ref-type="bibr" rid="bib34">Eastman et al., 2017</xref>) as graphic processing units (GPU)-based MD engines while offering the option to run also on CPUs.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>mwSuMD protocol</title><p>The SuMD is an adaptive sampling method (<xref ref-type="bibr" rid="bib21">Deganutti and Moro, 2017</xref>) based on a tabu-like algorithm for speeding up the simulation of binding events between small molecules (or peptides [<xref ref-type="bibr" rid="bib88">Salmaso et al., 2017</xref>; <xref ref-type="bibr" rid="bib11">Bower et al., 2018</xref>]) and proteins (<xref ref-type="bibr" rid="bib18">Cuzzolin et al., 2016</xref>; <xref ref-type="bibr" rid="bib87">Sabbadin and Moro, 2014</xref>) without the introduction of any energetic bias. Briefly, during SuMD, a series of short unbiased MD simulations are performed, and after each simulation, the distances between the centers of mass (or the geometrical centers) of the ligand and the predicted binding site (collected at regular time intervals) are fitted to a linear function. If the resulting slope is negative (showing progress toward the target), the next simulation step starts from the last set of coordinates and velocities, otherwise, the simulation is restarted by randomly assigning the atomic velocities.</p><p>mwSuMD is designed to increase the sampling from a specific configuration by seeding user-decided parallel replicas (walkers) rather than one short simulation as per SuMD. Since one replica for each batch of walkers is always considered productive, mwSuMD gives more control than SuMD on the total wall-clock time used for a simulation. On the flip side, to maximize mwSuMD, it is optimal to assign one walker per GPU, requiring multiple GPUs to be effective. However, modern multi-threaded GPUs can still employ mwSuMD with a smaller cost in GPU performance. In the implementation for ACEMD used in this work, mwSuMD needs as input the initial coordinates of the system as a pdb file, the coordinates, and the atomic velocities of the system from the equilibration stage, the topology file of the system, and all the necessary force field parameters. The user can decide to supervise one (X) or two metrics (X’, X’’) of the simulated system over short simulations seeded in batches, called walkers. In the former case, either the slope of the linear function interpolating the metric values or a score can be adopted to decide whether to continue the mwSuMD simulation. When the user decides to supervise two metrics, a specific score is used. In the present work, distances between centroids, RMSDs, or the number of atomic contacts between two selections were supervised (<xref ref-type="table" rid="table1">Table 1</xref>). The choice of the metrics is system and problem-dependent, as the RMSD is most useful when the final state is known, while the distance is required when the target state is unknown; details on the scores are given below. The decision to restart or continue mwSuMD after any short simulation is postponed until all the walkers of a batch are collected. The best short simulation is selected and extended by seeding the same number of walkers, with the same duration as the step before.</p><p>For each walker, the score for the supervision of a single metric (SMscore) is computed as the square root of the product between the metric value in the last frame (X<sub>last frame</sub>) and the average metric value over the short simulation (X̅):<disp-formula id="equ1"><label>(1)</label><mml:math id="m1"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>S</mml:mi><mml:mi>M</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:msqrt><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>∗</mml:mo><mml:mrow><mml:mover><mml:mi>X</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover></mml:mrow></mml:msqrt></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>If the metric is set to decrease (e.g. binding or dimerization) the walker with the lowest SMscore is continued, otherwise (e.g. unbinding or outward opening of domains), the walker with the highest score is continued. Using the SMscore rather than the slope should give more weight to the final state of each short simulation, as it is the starting point for the successive batch of simulations. Considering the average of the metric should favor short simulations consistently evolving in the desired direction along the metric.</p><p>If both X’ and X’’ are set to increase during the mwSuMD simulations, the score for the supervision of two metrics (DMscore) on each walker is computed as follows:<disp-formula id="equ2"><label>(2)</label><mml:math id="m2"><mml:mrow><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>D</mml:mi><mml:mi>M</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:msubsup><mml:mi>X</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">′</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mover><mml:mi>X</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>k</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">′</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:mfrac><mml:msubsup><mml:mi>X</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>t</mml:mi><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>e</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">′</mml:mi><mml:mi mathvariant="normal">′</mml:mi></mml:mrow></mml:msubsup><mml:msubsup><mml:mrow><mml:mover><mml:mi>X</mml:mi><mml:mo stretchy="false">¯</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>w</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mi>k</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>s</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">′</mml:mi><mml:mi mathvariant="normal">′</mml:mi></mml:mrow></mml:msubsup></mml:mfrac><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mo>)</mml:mo></mml:mrow><mml:mo>∗</mml:mo><mml:mn>100</mml:mn></mml:mstyle></mml:mrow></mml:math></disp-formula></p><p>where X’<sub>last frame</sub> and X’’<sub>last frame</sub> are the metrics values in the last frame, while X̅<sup>’</sup><sub>batch walkers</sub> and X̅<sup>’’</sup><sub>batch walkers</sub> represent the average value of the two metrics over all the walkers in the batch. Subtracting the value 1 to the metric ratio ensures that if one of the two metrics from the last frame (X’<sub>last frame</sub> or X<sup>’’</sup><sub>last frame</sub>) is equal to the average (X̅<sup>’’</sup><sub>batch walkers</sub> or X̅<sup>’’</sup><sub>batch walkers</sub>), then that metric addend is null, and DMscore depends only on the remaining metric. If any of the two metrics is set to decrease, then the corresponding component in <xref ref-type="disp-formula" rid="equ2">Equation 2</xref> is multiplied by –1 to maintain a positive score. Considering the average value of the two metrics over all the walkers rather than only over the considered walker should be more representative of the system evolution along the defined metric. In other words, the information about the metric is taken from all the walkers to better describe the evolution of the system.</p><p>The DMScore is designed to preserve some degree of independence between the two metrics supervised. Indeed, if the variation of one of them slows down and gets close to zero, the other metric is still able to drive the system’s evolution. It should be noted that DMScore works at its best if the two metrics have similar variations over time, as in the case of distance and RMSD (both of which are distance-based). Notably, differently from SuMD, when a walker is extended by seeding a new batch of short simulations and the remaining walkers are stopped, the atomic velocities are not reassigned. This allows the simulations to be as short as a few picoseconds if desired, without introducing artifacts due to the thermostat latency to reach the target temperature (usually up to 10–20 ps when a simulation is restarted, reassigning the velocities of the atoms).</p><p>The current implementation of mwSuMD is for Python3 and exploits MDAnalysis (<xref ref-type="bibr" rid="bib77">Michaud-Agrawal et al., 2011</xref>) and MDTRaj (<xref ref-type="bibr" rid="bib74">McGibbon et al., 2015</xref>) modules.</p></sec><sec id="s4-2"><title>Force field, ligands parameters, and general systems preparation</title><p>The CHARMM36 (<xref ref-type="bibr" rid="bib51">Huang and MacKerell, 2013</xref>; <xref ref-type="bibr" rid="bib52">Huang et al., 2017</xref>) /CGenFF 3.0.1 (<xref ref-type="bibr" rid="bib97">Vanommeslaeghe and MacKerell, 2012</xref>; <xref ref-type="bibr" rid="bib98">Vanommeslaeghe et al., 2012</xref>; <xref ref-type="bibr" rid="bib105">Yu et al., 2012</xref>) force field combination was employed in this work. Initial ligand force field, topology, and parameter files were obtained from the ParamChem webserver (<xref ref-type="bibr" rid="bib97">Vanommeslaeghe and MacKerell, 2012</xref>). Restrained electrostatic potential (<xref ref-type="bibr" rid="bib101">Woods and Chappelle, 2000</xref>) partial charges were assigned to all the non-peptidic small molecules but adrenaline and GDP using Gaussian09 (HF/6-31G* level of theory) and AmberTools20.</p><p>Six systems were prepared for MD (<xref ref-type="table" rid="table1">Table 1</xref>). Hydrogen atoms were added using the pdb2pqr (<xref ref-type="bibr" rid="bib29">Dolinsky et al., 2004</xref>) and propka (<xref ref-type="bibr" rid="bib80">Olsson et al., 2011</xref>) software (considering a simulated pH of 7.0); the protonation of titratable side chains was checked by visual inspection. The resulting receptors were separately inserted in a 1-palmitoyl-2-oleyl-<italic>sn</italic>-glycerol-3-phosphocholine (POPC) bilayer (previously built by using the VMD Membrane Builder plugin 1.1, Membrane Plugin, Version 1.1, at <ext-link ext-link-type="uri" xlink:href="http://www.ks.uiuc.edu/Research/vmd/plugins/membrane/">http://www.ks.uiuc.edu/Research/vmd/plugins/membrane/</ext-link>), through an insertion method (<xref ref-type="bibr" rid="bib90">Sommer, 2013</xref>). Receptor orientation was obtained by superposing the coordinates on the corresponding structure retrieved from the OPM database (<xref ref-type="bibr" rid="bib67">Lomize et al., 2006</xref>). Lipids overlapping the receptor TM helical bundle were removed and TIP3P water molecules (<xref ref-type="bibr" rid="bib57">Jorgensen et al., 1983</xref>) were added to the simulation box employing the VMD Solvate plugin 1.5 (Solvate Plugin, Version 1.5. at <ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/plugins/solvate/">https://www.ks.uiuc.edu/Research/vmd/plugins/solvate/</ext-link>). Finally, overall charge neutrality was reached by adding Na<sup>+</sup>/Cl<sup>-</sup> counterions up to the final concentration of 0.150 M, using the VMD Autoionize plugin 1.3 (Autoionize Plugin, Version 1.3. at <ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/plugins/autoionize/">https://www.ks.uiuc.edu/Research/vmd/plugins/autoionize/</ext-link>).</p></sec><sec id="s4-3"><title>System equilibration and general MD settings</title><p>The MD engine ACEMD3 (<xref ref-type="bibr" rid="bib49">Harvey et al., 2009</xref>) was employed for both the equilibration and productive simulations. The equilibration was achieved in isothermal-isobaric conditions (NPT) using the Berendsen barostat (<xref ref-type="bibr" rid="bib6">Berendsen et al., 1984</xref>) (target pressure 1 atm) and the Langevin thermostat (<xref ref-type="bibr" rid="bib68">Loncharich et al., 1992</xref>) (target temperature 300 K) with low damping of 1 ps<sup>–1</sup>. For the equilibration (integration time step of 2 fs): first, clashes between protein and lipid atoms were reduced through 1500 conjugate-gradient minimization steps, then a positional constraint of 1 kcal mol<sup>–1</sup> Å<sup>–2</sup> on all heavy atoms was gradually released over different time windows: 2 ns for lipid phosphorus atoms, 60 ns for protein atoms other than alpha carbon atoms, 80 ns for alpha carbon atoms; a further 20 ns of equilibration was performed without any positional constraints.</p><p>Productive trajectories (<xref ref-type="table" rid="table1">Table 1</xref>) were computed with an integration time step of 4 fs in the canonical ensemble (NVT). The target temperature was set at 300 K, using a thermostat damping of 0.1 ps<sup>–1</sup>; the M-SHAKE algorithm (<xref ref-type="bibr" rid="bib40">Forester and Smith, 1998</xref>; <xref ref-type="bibr" rid="bib62">Kräutler et al., 2001</xref>) was employed to constrain the bond lengths involving hydrogen atoms. The cutoff distance for electrostatic interactions was set at 9 Å, with a switching function applied beyond 7.5 Å. Long-range Coulomb interactions were handled using the particle mesh Ewald summation method (<xref ref-type="bibr" rid="bib35">Essmann et al., 1995</xref>) by setting the mesh spacing to 1.0 Å.</p></sec><sec id="s4-4"><title>Vasopressin binding simulations</title><p>The V<sub>2</sub>R in complex with vasopressin (AVP) and the G<sub>s</sub> protein (<xref ref-type="bibr" rid="bib111">Zhou et al., 2021</xref>) was retrieved from the Protein Data Bank (<xref ref-type="bibr" rid="bib8">Berman et al., 2000</xref>) (PDB 7DW9). The G<sub>s</sub> was removed from the system and the missing residues on ECL2 (G185-G189) were modeled from scratch using Modeller 9.19 (<xref ref-type="bibr" rid="bib36">Fiser and Sali, 2003</xref>), considering the solution with the lowest DOPE score out of 10 conformations produced. AVP was placed away from V<sub>2</sub>R in the extracellular bulk and the resulting system was prepared for MD simulations and equilibrated as reported above.</p><p>During SuMD simulations, the distance between the centroids of AVP residues C1-Q4 (backbone and side chains), anticipated to bind deep into V<sub>2</sub>R, and the V<sub>2</sub>R residues lining the peptide binding site Q96, Q174, Q291, and L312 (Cα atoms only) was supervised over time windows of 600 ps or 100 ps (<xref ref-type="table" rid="table1">Table 1</xref>). mwSuMD simulations considered the same distance, the RMSD of AVP residues C1-Q4 to the experimental bound complex, or the combination of the two during time windows of 600 ps (3 walkers) or 100 ps (10 walkers) (<xref ref-type="table" rid="table1">Table 1</xref>). Slope, SMscore, or DMscore (see Methods section mwSuMD protocol) was used in the different mwSuMD replicas performed (<xref ref-type="table" rid="table1">Table 1</xref>). Simulations were stopped after 300 ns (time window duration = 600 ps) or 50 ns (time window duration = 100 ps) of total SuMD or mwSuMD simulation time.</p></sec><sec id="s4-5"><title>Vasopressin unbinding simulations</title><p>The V<sub>2</sub>R:AVP complex was prepared for MD simulations and equilibrated as reported above. During both SuMD and mwSuMD simulations (<xref ref-type="table" rid="table1">Table 1</xref>), the distance between the centroids of AVP residues C1-Q4 (backbone and side chains) and V<sub>2</sub>R residues Q96, Q174, Q291, and L312 (Cα atoms only) was supervised over time windows of 100 ps (10 walkers seeded for mwSuMD simulations). Replicas were stopped when the AVP-V<sub>2</sub>R distance reached 40 Å.</p></sec><sec id="s4-6"><title>GLP-1R:PF06882961 binding simulations</title><p>The inactive GLP-1R was retrieved from the Protein Data Bank (<xref ref-type="bibr" rid="bib8">Berman et al., 2000</xref>) (PDB 6LN2) (<xref ref-type="bibr" rid="bib104">Wu et al., 2020</xref>). Fab and the intracellular negative allosteric modulator were removed, and missing residues in the stalk (129–134) and ICL2 (256–263) were modeled with Modeller 9.19, considering the solutions with the lowest DOPE score out of 10 conformations produced. The PF06882961 initial conformation was extracted from the complex with the fully active GLP-1R (<xref ref-type="bibr" rid="bib109">Zhang et al., 2021</xref>) (PDB 7LCJ) and placed away from GLP-1R in the extracellular bulk. The resulting system was prepared for MD simulations and equilibrated as reported above. CGenFF dihedral force field parameters of PF06882961 with the highest penalties (dihedrals NG2R51-CG321-CG3C41-CG3C41 [penalty = 143.5] and NG2R51-CG321-CG3C41-OG3C51 [penalty = 152.4]) were optimized (<xref ref-type="fig" rid="fig6">Figure 6a</xref>) employing Gaussian09 (geometric optimization and dihedral scan at HF/6-31g(d) level of theory) and the VMD force field toolkit plugin (<xref ref-type="bibr" rid="bib73">Mayne et al., 2013</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Preparation to GLP-1R mwSuMD simulations.</title><p>(<bold>a</bold>) Potential energy surface derived from the scan of the PF06882961 rotatable bond through which the dihedrals NG2R51-CG321-CG3C41-CG3C41 (penalty = 143.5) and NG2R51-CG321-CG3C41-OG3C51 (penalty = 152.4) pass. The curve obtained from the original CGenFF parameters (red) was optimized (blue) to resemble the energy profile from quantum-mechanics computations at the HF/6-31g(d) level of theory (black). (<bold>b</bold>) Distances between glucagon-like peptide-1 receptor (GLP-1R) key residues E138<sup>1.33</sup> and W214<sup>ECL1</sup> (black), H363<sup>6.52</sup> and F390<sup>7.45</sup> (blue) and Q47<sup>ECD</sup> and S310<sup>ECL2</sup> (red) during 8 μs of classic molecular dynamics (MD); (<bold>c</bold>) positions of the three couples of residues reported as two-side views.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-96513-fig6-v1.tif"/></fig><p>Four classic MD replicas, for a total of 8 μs, were performed on the inactive receptor (prepared for MD simulations and equilibrated as reported above) to assess the possible binding path to the receptor TMD and therefore decide the initial position of PF06882961 in the extracellular bulk of the simulation box. A visual inspection of the trajectories suggested three major conformational changes that could allow ligand access to the TMD (<xref ref-type="fig" rid="fig5">Figure 5b and c</xref>). Transitory openings of the ECD (distance Q47<sup>ECD</sup>-S310<sup>ECL2</sup>), TM6-TM7 (distance H363<sup>6.52</sup>-F390<sup>7.45</sup>), and TM1-ECL1 (distance E138<sup>1.33</sup> and W214<sup>ECL1</sup>) were observed. Since the opening of TM1-ECL1 was observed in two replicas out of four, we placed the ligand in a favorable position for crossing that region of GLP-1R.</p><p>mwSuMD simulations (<xref ref-type="table" rid="table1">Table 1</xref>) were performed stepwise to dock the ligand within GLP-1R first and then relax the receptor toward the active state. The PF06882961 binding was obtained by supervising at the same time the distance between the ligand’s heavy atoms centroid and the centroid of GLP-1R TM7 residues L379<sup>7.34</sup>-F381<sup>7.36</sup> (Cα atoms only), which are part of the orthosteric site, and the RMSD of the ECD (residues W33<sup>ECD</sup>-W120<sup>ECD</sup>, Cα atoms only) to the active state (PDB 7LCJ) until the former distance reached 4 Å. In the second phase of mwSuMD, the RMSD of the ECD (residues W33<sup>ECD</sup>-W120<sup>ECD</sup>, Cα atoms only) and the ECL1 to the active state (PDB 7LCJ, Cα atoms of residues M204<sup>2.74</sup>-L224<sup>3.27</sup>) were supervised until the latter reached less than 4 Å. During the third phase, the RMSDs of PF06882961, as well as the RMSD of ECL3 (residues A368<sup>6.57</sup>-T378<sup>7.33</sup>, Cα atoms), were supervised until the former reached values lower than 3 Å. In the last mwSuMD step, only the RMSD of TM6 (residues I345<sup>6.34</sup>-F367<sup>6.56</sup>, Cα atoms) to the active state (PDB 7LCJ) was supervised until less than 5 Å. RMSDs were computed after superimposition on TM2, ECL1, and TM3 residues 170–240 (Cα atoms), which is the GLP-1R less flexible part (<xref ref-type="bibr" rid="bib27">Deganutti et al., 2022</xref>).</p></sec><sec id="s4-7"><title>Membrane-anchored G<sub>s</sub> protein:GLP-1R simulations and GDP dissociation</title><p>The PDB 6EG8 was processed through Charmm-GUI (<xref ref-type="bibr" rid="bib56">Jo et al., 2008</xref>) to palmitoylate residue C3<sup>Gαi</sup> and geranylgeranylate residue C65<sup>Gγ</sup>. The resulting system was inserted into a 120×120 Å POPC membrane and previously built by using the VMD Membrane Builder plugin 1.1, Membrane Plugin, Version 1.1, at <ext-link ext-link-type="uri" xlink:href="http://www.ks.uiuc.edu/Research/vmd/plugins/membrane">http://www.ks.uiuc.edu/Research/vmd/plugins/membrane</ext-link>. Lipids overlapping the palmitoyl and geranylgeranyl groups were removed and TIP3P water molecules (<xref ref-type="bibr" rid="bib57">Jorgensen et al., 1983</xref>) were added to the simulation box by means of the VMD Solvate plugin 1.5 (Solvate Plugin, Version 1.5. at <ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/plugins/solvate/">https://www.ks.uiuc.edu/Research/vmd/plugins/solvate/</ext-link>). Finally, overall charge neutrality was reached by adding Na<sup>+</sup>/Cl<sup>-</sup> counterions up to the final concentration of 0.150 M, using the VMD Autoionize plugin 1.3 (Autoionize Plugin, Version 1.3. at <ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/plugins/autoionize/">https://www.ks.uiuc.edu/Research/vmd/plugins/autoionize/</ext-link>). The first stage of equilibration was performed as reported above (Methods section System equilibration and general MD settings) for 120 ns, followed by a second stage in the NVT ensemble for a further 1 μs without any restraints to allow the membrane-anchored heterotrimeric G<sub>s</sub> protein to stabilize within the intracellular side of the simulation box. After this two-stage long equilibration, GLP-1R from the final frame of the activation simulation (in complex with PF06882961) was manually inserted into the equilibrated membrane above the G<sub>s</sub> protein using the corresponding structure retrieved from the OPM database as a reference, and the system further equilibrated for 120 ns as reported above (Methods section System equilibration and general MD settings). The GLP-1R-G<sub>s</sub> system was then subjected to three simulations (<xref ref-type="table" rid="table1">Table 1</xref>). Each mwSuMD replica was interrupted by 500 ns of classic MD twice, to relax the system during the transition. In the supervised stages, the distance between residues M386-L394 <sup>Gαs</sup> (all-atoms centroid) of helix 5 (α5) and the GLP-1R intracellular residues R176<sup>2.46</sup>, R348<sup>6.37</sup>, S352<sup>6.41</sup>, and N405<sup>7.60</sup> (Cα atoms only) was monitored, seeding 3 walkers of 200 ps each.</p><p>The AHD opening was simulated starting from the GLP-1R:G<sub>s</sub> binding mwSuMD replica with the final lowest G<sub>s</sub> RMSD, the lowest PF06882961 binding energy and the highest GDP binding energy (Replica 2 in <xref ref-type="fig" rid="fig5">Figure 5e</xref>) by supervising the distance between AHD residues G70-R199<sup>Gαs</sup> and K300-L394<sup>Gαs</sup> (all-atoms centroids) during 3 walkers of 100 ps each. 300 ns of classic MD was performed to relax the system. Finally, the GDP unbinding was supervised as the distance between GDP (all-atoms centroid) and residues E50<sup>Gαs</sup>, K52<sup>Gαs</sup>, T55<sup>Gαs</sup>, K293<sup>Gαs</sup>, and V367<sup>Gαs</sup> (Cα atoms only) of Gα<sub>s</sub>; 5 walkers were used in a 50-ps-long mwSuMD simulations.</p></sec><sec id="s4-8"><title>MD analysis</title><p>Interatomic distances were computed through MDAnalysis <xref ref-type="bibr" rid="bib77">Michaud-Agrawal et al., 2011</xref>; RMSD were computed using VMD (<xref ref-type="bibr" rid="bib53">Humphrey et al., 1996</xref>) and MDAnalysis (<xref ref-type="bibr" rid="bib77">Michaud-Agrawal et al., 2011</xref>). Interatomic contacts and ligand-protein hydrogen bonds were detected using the GetContacts scripts tool (<ext-link ext-link-type="uri" xlink:href="https://getcontacts.github.io">https://getcontacts.github.io</ext-link>), setting a hydrogen bond donor-acceptor distance of 3.3 Å and an angle value of 120° as geometrical cutoffs. Contacts and hydrogen bond persistency are quantified as the percentage of frames (over all the frames obtained by merging the different replicas) in which protein residues formed contacts or hydrogen bonds with the ligand.</p><p>The MMPBSA.py (<xref ref-type="bibr" rid="bib78">Miller et al., 2012</xref>) script, from the AmberTools20 suite (The Amber Molecular Dynamics Package, at <ext-link ext-link-type="uri" xlink:href="http://ambermd.org/">http://ambermd.org/</ext-link>), was used to compute MM/GBSA method or the molecular mechanics MM/PBSA approach, after transforming the CHARMM psf topology files to an Amber prmtop format using ParmEd (documentation at <ext-link ext-link-type="uri" xlink:href="https://parmed.github.io/ParmEd/html/index.html">https://parmed.github.io/ParmEd/html/index.html</ext-link>).</p><p>Supplementary videos were produced employing VMD and avconv (at <ext-link ext-link-type="uri" xlink:href="https://libav.org/avconv.html">https://libav.org/avconv.html</ext-link>). Molecular graphics images were produced using the UCSF Chimera (<xref ref-type="bibr" rid="bib82">Pettersen et al., 2004</xref>) (Version 1.14).</p></sec><sec id="s4-9"><title>G<sub>s</sub> protein:β<sub>2</sub> AR binding simulations</title><p>mwSuMD simulations started from a not fully active, agonist-bound conformation of the β<sub>2</sub> AR and the inactive G<sub>s</sub> to resemble pre-coupling conditions. The full-length model of the adrenergic β<sub>2</sub> receptor (β<sub>2</sub> AR) in a not fully active state was downloaded from GPCRdb (<ext-link ext-link-type="uri" xlink:href="https://gpcrdb.org/">https://gpcrdb.org/</ext-link>). The full agonist adrenaline (ALE) was inserted in the orthosteric site by superposition with the PDB ID 4LDO (fully active β<sub>2</sub> AR) (<xref ref-type="bibr" rid="bib86">Ring et al., 2013</xref>). The structure of the inactive, GDP-bound G<sub>s</sub> protein (<xref ref-type="bibr" rid="bib66">Liu et al., 2019</xref>) was retrieved from the Protein Data Bank (<xref ref-type="bibr" rid="bib8">Berman et al., 2000</xref>) (PDB ID 6EG8) and placed in the intracellular bulk. The resulting system (G<sub>s</sub> &gt;50 Å away from β<sub>2</sub> AR) was prepared for MD simulations and equilibrated as reported above. The PDB ID 3SN6 (fully active β<sub>2</sub> AR in complex with G<sub>s</sub> [<xref ref-type="bibr" rid="bib85">Rasmussen et al., 2011</xref>]) was used as the reference for RMSD computations. Three mwSuMD replicas (<xref ref-type="table" rid="table1">Table 1</xref>) were performed supervising at the same time the distance between the helix 5 (α5) Gα<sub>s</sub> residues R385-L395 (Cα atoms centroid) and the β<sub>2</sub> AR (residues V31-P330 Cα atoms centroid) as well as the RMSD (superimposing on β<sub>2</sub> AR residues 70–170 Cα atoms) of β<sub>2</sub> AR TM6 residues C265-I278 (Cα atoms only) to the fully active state, during 100 ps time windows (5 walkers). To monitor the progression of the simulations, we computed the RMSD of the Cα atoms of the Gα (residues 11–43 and residues 205–394) and Gβ subunits (residues 3–340) to the experimental complex (<xref ref-type="bibr" rid="bib85">Rasmussen et al., 2011</xref>; <xref ref-type="video" rid="video3">Video 3</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). The flexibility of G<sub>s</sub>β is backed by both MD and cryo-EM data suggesting G protein rocking motions around G<sub>s</sub>α:receptor interactions (<xref ref-type="bibr" rid="bib30">Dong et al., 2020</xref>; <xref ref-type="bibr" rid="bib64">Liang et al., 2020</xref>).</p></sec><sec id="s4-10"><title>Membrane-anchored G<sub>i</sub> protein:A<sub>1</sub>R simulations</title><p>Since the full-length structure of the inactive human G<sub>i</sub> protein has not yet been resolved by X-ray or cryo-EM, it was modeled by superimposing the AlphaFold2 (<xref ref-type="bibr" rid="bib58">Jumper et al., 2021</xref>) AI models of the Gα<sub>i</sub> (P63096-F1), Gβ (Q9HAV0-F1), and Gγ (P50151-F1) subunits to the PDB file 6EG8 (a G<sub>s</sub> heterotrimer). The resulting homotrimer (without GDP) was processed through Charmm-GUI (<xref ref-type="bibr" rid="bib56">Jo et al., 2008</xref>) to palmitoylate residue C3<sup>Gαi</sup> and geranylgeranylate residue C65<sup>Gγ</sup> (<xref ref-type="bibr" rid="bib65">Linder et al., 1993</xref>; <xref ref-type="bibr" rid="bib79">Mystek et al., 2019</xref>). The side chains of these two lipidated residues were manually inserted into a 120×120 Å POPC membrane and previously built by using the VMD Membrane Builder plugin 1.1, Membrane Plugin, Version 1.1. at <ext-link ext-link-type="uri" xlink:href="http://www.ks.uiuc.edu/Research/vmd/plugins/membrane/">http://www.ks.uiuc.edu/Research/vmd/plugins/membrane/</ext-link>. Lipids overlapping the palmitoyl and geranylgeranyl groups were removed and TIP3P water molecules (<xref ref-type="bibr" rid="bib57">Jorgensen et al., 1983</xref>) were added to the simulation box by means of the VMD Solvate plugin 1.5 (Solvate Plugin, Version 1.5. at <ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/plugins/solvate/">https://www.ks.uiuc.edu/Research/vmd/plugins/solvate/</ext-link>). Finally, overall charge neutrality was reached by adding Na<sup>+</sup>/Cl<sup>-</sup> counterions up to the final concentration of 0.150 M, using the VMD Autoionize plugin 1.3 (Autoionize Plugin, Version 1.3. at <ext-link ext-link-type="uri" xlink:href="https://www.ks.uiuc.edu/Research/vmd/plugins/autoionize/">https://www.ks.uiuc.edu/Research/vmd/plugins/autoionize/</ext-link>). The first stage of equilibration was performed as reported above (Methods section System equilibration and general MD settings) for 120 ns, followed by a second stage in the NVT ensemble for a further 1 μs without any restraints to allow the membrane-anchored heterotrimeric G<sub>i</sub> protein to stabilize within the intracellular side of the simulation box. After this two-stage long equilibration, the active state A<sub>1</sub>R in complex with adenosine (PDB 6D9H) was manually inserted into the equilibrated membrane above the G<sub>i</sub> protein using the corresponding structure retrieved from the OPM database as a reference, and the system further equilibrated for 120 ns as reported in the Methods section System equilibration and general MD settings. The A<sub>1</sub>R-G<sub>i</sub> system was then subjected to a 1-μs-long classic MD simulation and an mwSuMD simulation (<xref ref-type="table" rid="table1">Table 1</xref>). During the mwSuMD simulation, the RMSD (superimposing on A<sub>1</sub>R residues 40–140 Cα atoms) of helix 5 (α5) Gα<sub>i</sub> residues 329–354 to the PDB 6D9H was supervised, seeding 3 walkers of 100 ps each until the productive simulation time reached 50 ns (total simulation time 150 ns).</p></sec><sec id="s4-11"><title>Numbering system</title><p>Throughout the manuscript, the Ballesteros-Weinstein residues numbering system for class A (<xref ref-type="bibr" rid="bib4">Ballesteros and Weinstein, 1995</xref>) and the Wootten residues numbering system for class B GPCRs (<xref ref-type="bibr" rid="bib102">Wootten et al., 2013</xref>) are adopted.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Software, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Investigation</p></fn><fn fn-type="con" id="con4"><p>Investigation</p></fn><fn fn-type="con" id="con5"><p>Investigation</p></fn><fn fn-type="con" id="con6"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Methodology, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-96513-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>MD trajectories available at <ext-link ext-link-type="uri" xlink:href="https://zenodo.org/records/7944479">https://zenodo.org/records/7944479</ext-link>. mwSuMD software is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/pipitoludovico/mwSuMD_multiEngine">https://github.com/pipitoludovico/mwSuMD_multiEngine</ext-link> (copy archived at <xref ref-type="bibr" rid="bib84">Pipitò, 2025</xref>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Updated MD trajectories for &quot;Hidden GPCR structural transitions addressed by multiple walker supervised molecular dynamics (mwSuMD)&quot;</data-title><source>Zenodo</source><pub-id pub-id-type="doi">10.5281/zenodo.7944479</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>GD is a member of the GPCRs-focused European COST action ERNEST. CAR is grateful for a Royal Society Industry Fellowship. GD and CAR are grateful for support from the BBSRC (BB/W016974/1) and Diabetes UK (BDA 20/0006307).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alba Ortíz</surname><given-names>A</given-names></name><name><surname>Vreede</surname><given-names>J</given-names></name><name><surname>Ensing</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The adaptive path collective variable: a versatile biasing approach to compute the average transition path and free energy of molecular transitions</article-title><source>Methods in Molecular Biology</source><volume>01</volume><fpage>255</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-9608-7_11</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasio</surname><given-names>S</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Addressing free fatty acid receptor 1 (FFAR1) activation using supervised molecular dynamics</article-title><source>Journal of Computer-Aided Molecular Design</source><volume>34</volume><fpage>1181</fpage><lpage>1193</lpage><pub-id pub-id-type="doi">10.1007/s10822-020-00338-6</pub-id><pub-id pub-id-type="pmid">32851580</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ball</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Vasopressin and disorders of water balance: the physiology and pathophysiology of vasopressin</article-title><source>Annals of Clinical Biochemistry</source><volume>44</volume><fpage>417</fpage><lpage>431</lpage><pub-id pub-id-type="doi">10.1258/000456307781646030</pub-id><pub-id pub-id-type="pmid">17761027</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Ballesteros</surname><given-names>JA</given-names></name><name><surname>Weinstein</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1995">1995</year><chapter-title>Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</chapter-title><person-group person-group-type="editor"><name><surname>Ballesteros</surname><given-names>JA</given-names></name><name><surname>Weinstein</surname><given-names>H</given-names></name></person-group><source>In Receptor Molecular Biology; Methods in Neurosciences</source><publisher-name>Elsevier</publisher-name><fpage>366</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/S1043-9471(05)80049-7</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batebi</surname><given-names>H</given-names></name><name><surname>Pérez-Hernández</surname><given-names>G</given-names></name><name><surname>Rahman</surname><given-names>SN</given-names></name><name><surname>Lan</surname><given-names>B</given-names></name><name><surname>Kamprad</surname><given-names>A</given-names></name><name><surname>Shi</surname><given-names>M</given-names></name><name><surname>Speck</surname><given-names>D</given-names></name><name><surname>Tiemann</surname><given-names>JKS</given-names></name><name><surname>Guixà-González</surname><given-names>R</given-names></name><name><surname>Reinhardt</surname><given-names>F</given-names></name><name><surname>Stadler</surname><given-names>PF</given-names></name><name><surname>Papasergi-Scott</surname><given-names>MM</given-names></name><name><surname>Skiniotis</surname><given-names>G</given-names></name><name><surname>Scheerer</surname><given-names>P</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name><name><surname>Mathiesen</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Hildebrand</surname><given-names>PW</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Mechanistic insights into G-protein coupling with an agonist-bound G-protein-coupled receptor</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>31</volume><fpage>1692</fpage><lpage>1701</lpage><pub-id pub-id-type="doi">10.1038/s41594-024-01334-2</pub-id><pub-id pub-id-type="pmid">38867113</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendsen</surname><given-names>HJC</given-names></name><name><surname>Postma</surname><given-names>JPM</given-names></name><name><surname>van Gunsteren</surname><given-names>WF</given-names></name><name><surname>DiNola</surname><given-names>A</given-names></name><name><surname>Haak</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>Molecular dynamics with coupling to an external bath</article-title><source>The Journal of Chemical Physics</source><volume>81</volume><fpage>3684</fpage><lpage>3690</lpage><pub-id pub-id-type="doi">10.1063/1.448118</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berendsen</surname><given-names>HJC</given-names></name><name><surname>van der Spoel</surname><given-names>D</given-names></name><name><surname>van Drunen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>GROMACS: a message-passing parallel molecular dynamics implementation</article-title><source>Computer Physics Communications</source><volume>91</volume><fpage>43</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/0010-4655(95)00042-E</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>HM</given-names></name><name><surname>Westbrook</surname><given-names>J</given-names></name><name><surname>Feng</surname><given-names>Z</given-names></name><name><surname>Gilliland</surname><given-names>G</given-names></name><name><surname>Bhat</surname><given-names>TN</given-names></name><name><surname>Weissig</surname><given-names>H</given-names></name><name><surname>Shindyalov</surname><given-names>IN</given-names></name><name><surname>Bourne</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The protein data bank</article-title><source>Nucleic Acids Research</source><volume>28</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id><pub-id pub-id-type="pmid">10592235</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnbaumer</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Vasopressin receptors</article-title><source>Trends in Endocrinology and Metabolism</source><volume>11</volume><fpage>406</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/s1043-2760(00)00304-0</pub-id><pub-id pub-id-type="pmid">11091117</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bokoch</surname><given-names>MP</given-names></name><name><surname>Jo</surname><given-names>H</given-names></name><name><surname>Valcourt</surname><given-names>JR</given-names></name><name><surname>Srinivasan</surname><given-names>Y</given-names></name><name><surname>Pan</surname><given-names>AC</given-names></name><name><surname>Capponi</surname><given-names>S</given-names></name><name><surname>Grabe</surname><given-names>M</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Shaw</surname><given-names>DE</given-names></name><name><surname>DeGrado</surname><given-names>WF</given-names></name><name><surname>Coughlin</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Entry from the lipid bilayer: a possible pathway for inhibition of a peptide G protein-coupled receptor by a lipophilic small molecule</article-title><source>Biochemistry</source><volume>57</volume><fpage>5748</fpage><lpage>5758</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.8b00577</pub-id><pub-id pub-id-type="pmid">30102523</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bower</surname><given-names>RL</given-names></name><name><surname>Yule</surname><given-names>L</given-names></name><name><surname>Rees</surname><given-names>TA</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Hendrikse</surname><given-names>ER</given-names></name><name><surname>Harris</surname><given-names>PWR</given-names></name><name><surname>Kowalczyk</surname><given-names>R</given-names></name><name><surname>Ridgway</surname><given-names>Z</given-names></name><name><surname>Wong</surname><given-names>AG</given-names></name><name><surname>Swierkula</surname><given-names>K</given-names></name><name><surname>Raleigh</surname><given-names>DP</given-names></name><name><surname>Pioszak</surname><given-names>AA</given-names></name><name><surname>Brimble</surname><given-names>MA</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Walker</surname><given-names>CS</given-names></name><name><surname>Hay</surname><given-names>DL</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular signature for receptor engagement in the metabolic peptide hormone amylin</article-title><source>ACS Pharmacology &amp; Translational Science</source><volume>1</volume><fpage>32</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1021/acsptsci.8b00002</pub-id><pub-id pub-id-type="pmid">32219203</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bussi</surname><given-names>G</given-names></name><name><surname>Laio</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Using metadynamics to explore complex free-energy landscapes</article-title><source>Nature Reviews Physics</source><volume>2</volume><fpage>200</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1038/s42254-020-0153-0</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cary</surname><given-names>BP</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Truong</surname><given-names>TT</given-names></name><name><surname>Piper</surname><given-names>SJ</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Gellman</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Structural and functional diversity among agonist-bound states of the GLP-1 receptor</article-title><source>Nature Chemical Biology</source><volume>18</volume><fpage>256</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1038/s41589-021-00945-w</pub-id><pub-id pub-id-type="pmid">34937906</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>LN</given-names></name><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Dai</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Eric Xu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>3763</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-24058-z</pub-id><pub-id pub-id-type="pmid">34145245</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>Z</given-names></name><name><surname>Liang</surname><given-names>YL</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Darbalaei</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>HE</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Structural perspective of class B1 GPCR signaling</article-title><source>Trends in Pharmacological Sciences</source><volume>43</volume><fpage>321</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2022.01.002</pub-id><pub-id pub-id-type="pmid">35078643</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>LN</given-names></name><name><surname>Zhang</surname><given-names>ZC</given-names></name><name><surname>Liang</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Dai</surname><given-names>A</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2200155119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2200155119</pub-id><pub-id pub-id-type="pmid">35561211</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Culhane</surname><given-names>KJ</given-names></name><name><surname>Gupte</surname><given-names>TM</given-names></name><name><surname>Madhugiri</surname><given-names>I</given-names></name><name><surname>Gadgil</surname><given-names>CJ</given-names></name><name><surname>Sivaramakrishnan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Kinetic model of GPCR-G protein interactions reveals allokairic modulation of signaling</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1202</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28789-5</pub-id><pub-id pub-id-type="pmid">35260563</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuzzolin</surname><given-names>A</given-names></name><name><surname>Sturlese</surname><given-names>M</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Salmaso</surname><given-names>V</given-names></name><name><surname>Sabbadin</surname><given-names>D</given-names></name><name><surname>Ciancetta</surname><given-names>A</given-names></name><name><surname>Moro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Deciphering the complexity of ligand-protein recognition pathways using supervised molecular dynamics (SuMD) simulations</article-title><source>Journal of Chemical Information and Modeling</source><volume>56</volume><fpage>687</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.5b00702</pub-id><pub-id pub-id-type="pmid">27019343</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D’Amore</surname><given-names>VM</given-names></name><name><surname>Conflitti</surname><given-names>P</given-names></name><name><surname>Marinelli</surname><given-names>L</given-names></name><name><surname>Limongelli</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Minute-timescale free-energy calculations reveal a pseudo-active state in the adenosine A<sub>2A</sub> receptor activation mechanism</article-title><source>Chem</source><volume>10</volume><fpage>3678</fpage><lpage>3698</lpage><pub-id pub-id-type="doi">10.1016/j.chempr.2024.08.004</pub-id><pub-id pub-id-type="pmid">40191447</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Mendoza</surname><given-names>A</given-names></name><name><surname>Sebé-Pedrós</surname><given-names>A</given-names></name><name><surname>Ruiz-Trillo</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The evolution of the GPCR signaling system in eukaryotes: modularity, conservation, and the transition to metazoan multicellularity</article-title><source>Genome Biology and Evolution</source><volume>6</volume><fpage>606</fpage><lpage>619</lpage><pub-id pub-id-type="doi">10.1093/gbe/evu038</pub-id><pub-id pub-id-type="pmid">24567306</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Moro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Estimation of kinetic and thermodynamic ligand-binding parameters using computational strategies</article-title><source>Future Medicinal Chemistry</source><volume>9</volume><fpage>507</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.4155/fmc-2016-0224</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Barkan</surname><given-names>K</given-names></name><name><surname>Ladds</surname><given-names>G</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>A multisite model of allosterism for the adenosine A1 receptor</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.10.14.338822</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Moro</surname><given-names>S</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>A Supervised molecular dynamics approach to unbiased ligand-protein unbinding</article-title><source>Journal of Chemical Information and Modeling</source><volume>60</volume><fpage>1804</fpage><lpage>1817</lpage><pub-id pub-id-type="doi">10.1021/acs.jcim.9b01094</pub-id><pub-id pub-id-type="pmid">32126172</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Atanasio</surname><given-names>S</given-names></name><name><surname>Rujan</surname><given-names>RM</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2021">2021a</year><article-title>Exploring ligand binding to calcitonin gene-related peptide receptors</article-title><source>Frontiers in Molecular Biosciences</source><volume>8</volume><elocation-id>720561</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2021.720561</pub-id><pub-id pub-id-type="pmid">34513925</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Barkan</surname><given-names>K</given-names></name><name><surname>Preti</surname><given-names>B</given-names></name><name><surname>Leuenberger</surname><given-names>M</given-names></name><name><surname>Wall</surname><given-names>M</given-names></name><name><surname>Frenguelli</surname><given-names>BG</given-names></name><name><surname>Lochner</surname><given-names>M</given-names></name><name><surname>Ladds</surname><given-names>G</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2021">2021b</year><article-title>Deciphering the agonist binding mechanism to the adenosine A1 receptor</article-title><source>ACS Pharmacology &amp; Translational Science</source><volume>4</volume><fpage>314</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1021/acsptsci.0c00195</pub-id><pub-id pub-id-type="pmid">33615181</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Prischi</surname><given-names>F</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="2021">2021c</year><article-title>Supervised molecular dynamics for exploring the druggability of the SARS-CoV-2 spike protein</article-title><source>Journal of Computer-Aided Molecular Design</source><volume>35</volume><fpage>195</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1007/s10822-020-00356-4</pub-id><pub-id pub-id-type="pmid">33103220</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Liang</surname><given-names>YL</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Khoshouei</surname><given-names>M</given-names></name><name><surname>Clydesdale</surname><given-names>L</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name><name><surname>Venugopal</surname><given-names>H</given-names></name><name><surname>Truong</surname><given-names>TT</given-names></name><name><surname>Glukhova</surname><given-names>A</given-names></name><name><surname>Keller</surname><given-names>AN</given-names></name><name><surname>Gregory</surname><given-names>KJ</given-names></name><name><surname>Leach</surname><given-names>K</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>92</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-27760-0</pub-id><pub-id pub-id-type="pmid">35013280</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickson</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>WExplore: hierarchical exploration of high-dimensional spaces using the weighted ensemble algorithm</article-title><source>The Journal of Physical Chemistry. B</source><volume>118</volume><fpage>3532</fpage><lpage>3542</lpage><pub-id pub-id-type="doi">10.1021/jp411479c</pub-id><pub-id pub-id-type="pmid">24490961</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolinsky</surname><given-names>TJ</given-names></name><name><surname>Nielsen</surname><given-names>JE</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name><name><surname>Baker</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</article-title><source>Nucleic Acids Research</source><volume>32</volume><fpage>W665</fpage><lpage>W667</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh381</pub-id><pub-id pub-id-type="pmid">15215472</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>M</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Piper</surname><given-names>SJ</given-names></name><name><surname>Liang</surname><given-names>YL</given-names></name><name><surname>Khoshouei</surname><given-names>M</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name><name><surname>Harikumar</surname><given-names>KG</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Glukhova</surname><given-names>A</given-names></name><name><surname>Furness</surname><given-names>SGB</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structure and dynamics of the active Gs-coupled human secretin receptor</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>4137</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17791-4</pub-id><pub-id pub-id-type="pmid">32811827</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dror</surname><given-names>RO</given-names></name><name><surname>Mildorf</surname><given-names>TJ</given-names></name><name><surname>Hilger</surname><given-names>D</given-names></name><name><surname>Manglik</surname><given-names>A</given-names></name><name><surname>Borhani</surname><given-names>DW</given-names></name><name><surname>Arlow</surname><given-names>DH</given-names></name><name><surname>Philippsen</surname><given-names>A</given-names></name><name><surname>Villanueva</surname><given-names>N</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Lerch</surname><given-names>MT</given-names></name><name><surname>Hubbell</surname><given-names>WL</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name><name><surname>Sunahara</surname><given-names>RK</given-names></name><name><surname>Shaw</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Structural basis for nucleotide exchange in heterotrimeric G proteins</article-title><source>Science</source><volume>348</volume><fpage>1361</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1126/science.aaa5264</pub-id><pub-id pub-id-type="pmid">26089515</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Duc</surname><given-names>NM</given-names></name><name><surname>Rasmussen</surname><given-names>SGF</given-names></name><name><surname>Hilger</surname><given-names>D</given-names></name><name><surname>Kubiak</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Bohon</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Wegrecki</surname><given-names>M</given-names></name><name><surname>Asuru</surname><given-names>A</given-names></name><name><surname>Jeong</surname><given-names>KM</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Chance</surname><given-names>MR</given-names></name><name><surname>Lodowski</surname><given-names>DT</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name><name><surname>Chung</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Assembly of a GPCR-G protein complex</article-title><source>Cell</source><volume>177</volume><fpage>1232</fpage><lpage>1242</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.04.022</pub-id><pub-id pub-id-type="pmid">31080064</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durrant</surname><given-names>JD</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular dynamics simulations and drug discovery</article-title><source>BMC Biology</source><volume>9</volume><elocation-id>71</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7007-9-71</pub-id><pub-id pub-id-type="pmid">22035460</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eastman</surname><given-names>P</given-names></name><name><surname>Swails</surname><given-names>J</given-names></name><name><surname>Chodera</surname><given-names>JD</given-names></name><name><surname>McGibbon</surname><given-names>RT</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Beauchamp</surname><given-names>KA</given-names></name><name><surname>Wang</surname><given-names>LP</given-names></name><name><surname>Simmonett</surname><given-names>AC</given-names></name><name><surname>Harrigan</surname><given-names>MP</given-names></name><name><surname>Stern</surname><given-names>CD</given-names></name><name><surname>Wiewiora</surname><given-names>RP</given-names></name><name><surname>Brooks</surname><given-names>BR</given-names></name><name><surname>Pande</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>OpenMM 7: rapid development of high performance algorithms for molecular dynamics</article-title><source>PLOS Computational Biology</source><volume>13</volume><elocation-id>e1005659</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1005659</pub-id><pub-id pub-id-type="pmid">28746339</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Essmann</surname><given-names>U</given-names></name><name><surname>Perera</surname><given-names>L</given-names></name><name><surname>Berkowitz</surname><given-names>ML</given-names></name><name><surname>Darden</surname><given-names>T</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Pedersen</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>A smooth particle mesh Ewald method</article-title><source>The Journal of Chemical Physics</source><volume>103</volume><fpage>8577</fpage><lpage>8593</lpage><pub-id pub-id-type="doi">10.1063/1.470117</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiser</surname><given-names>A</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Modeller: generation and refinement of homology-based protein structure models</article-title><source>Methods in Enzymology</source><volume>374</volume><fpage>461</fpage><lpage>491</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(03)74020-8</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleetwood</surname><given-names>O</given-names></name><name><surname>Matricon</surname><given-names>P</given-names></name><name><surname>Carlsson</surname><given-names>J</given-names></name><name><surname>Delemotte</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Energy landscapes reveal agonist control of G protein-coupled receptor activation via microswitches</article-title><source>Biochemistry</source><volume>59</volume><fpage>880</fpage><lpage>891</lpage><pub-id pub-id-type="doi">10.1021/acs.biochem.9b00842</pub-id><pub-id pub-id-type="pmid">31999436</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flock</surname><given-names>T</given-names></name><name><surname>Ravarani</surname><given-names>CNJ</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Venkatakrishnan</surname><given-names>AJ</given-names></name><name><surname>Kayikci</surname><given-names>M</given-names></name><name><surname>Tate</surname><given-names>CG</given-names></name><name><surname>Veprintsev</surname><given-names>DB</given-names></name><name><surname>Babu</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Universal allosteric mechanism for Gα activation by GPCRs</article-title><source>Nature</source><volume>524</volume><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/nature14663</pub-id><pub-id pub-id-type="pmid">26147082</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flock</surname><given-names>T</given-names></name><name><surname>Hauser</surname><given-names>AS</given-names></name><name><surname>Lund</surname><given-names>N</given-names></name><name><surname>Gloriam</surname><given-names>DE</given-names></name><name><surname>Balaji</surname><given-names>S</given-names></name><name><surname>Babu</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Selectivity determinants of GPCR-G-protein binding</article-title><source>Nature</source><volume>545</volume><fpage>317</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1038/nature22070</pub-id><pub-id pub-id-type="pmid">28489817</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forester</surname><given-names>TR</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>SHAKE, rattle, and roll: efficient constraint algorithms for linked rigid bodies</article-title><source>Journal of Computational Chemistry</source><volume>19</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-987X(19980115)19:1&lt;102::AID-JCC9&gt;3.0.CO;2-T</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gioia</surname><given-names>D</given-names></name><name><surname>Bertazzo</surname><given-names>M</given-names></name><name><surname>Recanatini</surname><given-names>M</given-names></name><name><surname>Masetti</surname><given-names>M</given-names></name><name><surname>Cavalli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dynamic docking: a paradigm shift in computational drug discovery</article-title><source>Molecules</source><volume>22</volume><elocation-id>2029</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22112029</pub-id><pub-id pub-id-type="pmid">29165360</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glukhova</surname><given-names>A</given-names></name><name><surname>Draper-Joyce</surname><given-names>CJ</given-names></name><name><surname>Sunahara</surname><given-names>RK</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rules of engagement: GPCRs and G proteins</article-title><source>ACS Pharmacology &amp; Translational Science</source><volume>1</volume><fpage>73</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1021/acsptsci.8b00026</pub-id><pub-id pub-id-type="pmid">32219204</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="web"><person-group person-group-type="author"><collab>G protein-coupled receptors</collab></person-group><year iso-8601-date="2019">2019</year><article-title>BPS Guide to PHARMACOLOGY</article-title><ext-link ext-link-type="uri" xlink:href="https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=694">https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=694</ext-link><date-in-citation iso-8601-date="2023-11-11">November 11, 2023</date-in-citation></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregorio</surname><given-names>GG</given-names></name><name><surname>Masureel</surname><given-names>M</given-names></name><name><surname>Hilger</surname><given-names>D</given-names></name><name><surname>Terry</surname><given-names>DS</given-names></name><name><surname>Juette</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name><name><surname>Perez-Aguilar</surname><given-names>JM</given-names></name><name><surname>Hauge</surname><given-names>M</given-names></name><name><surname>Mathiasen</surname><given-names>S</given-names></name><name><surname>Javitch</surname><given-names>JA</given-names></name><name><surname>Weinstein</surname><given-names>H</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name><name><surname>Blanchard</surname><given-names>SC</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-molecule analysis of ligand efficacy in β<sub>2</sub>AR-G-protein activation</article-title><source>Nature</source><volume>547</volume><fpage>68</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/nature22354</pub-id><pub-id pub-id-type="pmid">28607487</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Heitman</surname><given-names>LH</given-names></name><name><surname>IJzerman</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The role of target binding kinetics in drug discovery</article-title><source>ChemMedChem</source><volume>10</volume><fpage>1793</fpage><lpage>1796</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201500310</pub-id><pub-id pub-id-type="pmid">26506404</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>D</given-names></name><name><surname>Heitman</surname><given-names>LH</given-names></name><name><surname>IJzerman</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Kinetic aspects of the interaction between ligand and G protein-coupled receptor: the case of the adenosine receptors</article-title><source>Chemical Reviews</source><volume>117</volume><fpage>38</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.6b00025</pub-id><pub-id pub-id-type="pmid">27088232</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ham</surname><given-names>D</given-names></name><name><surname>Ahn</surname><given-names>D</given-names></name><name><surname>Ashim</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Chung</surname><given-names>KY</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Conformational switch that induces GDP release from Gi</article-title><source>Journal of Structural Biology</source><volume>213</volume><elocation-id>107694</elocation-id><pub-id pub-id-type="doi">10.1016/j.jsb.2020.107694</pub-id><pub-id pub-id-type="pmid">33418033</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamelberg</surname><given-names>D</given-names></name><name><surname>Mongan</surname><given-names>J</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Accelerated molecular dynamics: a promising and efficient simulation method for biomolecules</article-title><source>The Journal of Chemical Physics</source><volume>120</volume><fpage>11919</fpage><lpage>11929</lpage><pub-id pub-id-type="doi">10.1063/1.1755656</pub-id><pub-id pub-id-type="pmid">15268227</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harvey</surname><given-names>MJ</given-names></name><name><surname>Giupponi</surname><given-names>G</given-names></name><name><surname>Fabritiis</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>ACEMD: accelerating biomolecular dynamics in the microsecond time scale</article-title><source>Journal of Chemical Theory and Computation</source><volume>5</volume><fpage>1632</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1021/ct9000685</pub-id><pub-id pub-id-type="pmid">26609855</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollingsworth</surname><given-names>SA</given-names></name><name><surname>Dror</surname><given-names>RO</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular dynamics simulation for all</article-title><source>Neuron</source><volume>99</volume><fpage>1129</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.011</pub-id><pub-id pub-id-type="pmid">30236283</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data</article-title><source>Journal of Computational Chemistry</source><volume>34</volume><fpage>2135</fpage><lpage>2145</lpage><pub-id pub-id-type="doi">10.1002/jcc.23354</pub-id><pub-id pub-id-type="pmid">23832629</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Jing</given-names></name><name><surname>Rauscher</surname><given-names>S</given-names></name><name><surname>Nawrocki</surname><given-names>G</given-names></name><name><surname>Ran</surname><given-names>T</given-names></name><name><surname>Feig</surname><given-names>M</given-names></name><name><surname>de Groot</surname><given-names>BL</given-names></name><name><surname>Grubmüller</surname><given-names>H</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names><suffix>Jr</suffix></name></person-group><year iso-8601-date="2017">2017</year><article-title>CHARMM36m: an improved force field for folded and intrinsically disordered proteins</article-title><source>Nature Methods</source><volume>14</volume><fpage>71</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/nmeth.4067</pub-id><pub-id pub-id-type="pmid">27819658</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humphrey</surname><given-names>W</given-names></name><name><surname>Dalke</surname><given-names>A</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>VMD: visual molecular dynamics</article-title><source>Journal of Molecular Graphics</source><volume>14</volume><fpage>33</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id><pub-id pub-id-type="pmid">8744570</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husic</surname><given-names>BE</given-names></name><name><surname>Pande</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Markov state models: from an art to a science</article-title><source>Journal of the American Chemical Society</source><volume>140</volume><fpage>2386</fpage><lpage>2396</lpage><pub-id pub-id-type="doi">10.1021/jacs.7b12191</pub-id><pub-id pub-id-type="pmid">29323881</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isberg</surname><given-names>V</given-names></name><name><surname>Mordalski</surname><given-names>S</given-names></name><name><surname>Munk</surname><given-names>C</given-names></name><name><surname>Rataj</surname><given-names>K</given-names></name><name><surname>Harpsøe</surname><given-names>K</given-names></name><name><surname>Hauser</surname><given-names>AS</given-names></name><name><surname>Vroling</surname><given-names>B</given-names></name><name><surname>Bojarski</surname><given-names>AJ</given-names></name><name><surname>Vriend</surname><given-names>G</given-names></name><name><surname>Gloriam</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GPCRdb: an information system for G protein-coupled receptors</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>D356</fpage><lpage>D364</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv1178</pub-id><pub-id pub-id-type="pmid">26582914</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Iyer</surname><given-names>VG</given-names></name><name><surname>Im</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>CHARMM-GUI: A web-based graphical user interface for CHARMM</article-title><source>Journal of Computational Chemistry</source><volume>29</volume><fpage>1859</fpage><lpage>1865</lpage><pub-id pub-id-type="doi">10.1002/jcc.20945</pub-id><pub-id pub-id-type="pmid">18351591</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>WL</given-names></name><name><surname>Chandrasekhar</surname><given-names>J</given-names></name><name><surname>Madura</surname><given-names>JD</given-names></name><name><surname>Impey</surname><given-names>RW</given-names></name><name><surname>Klein</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Comparison of simple potential functions for simulating liquid water</article-title><source>The Journal of Chemical Physics</source><volume>79</volume><fpage>926</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.1063/1.445869</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Yoshino</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Fukazawa</surname><given-names>M</given-names></name><name><surname>Nagao</surname><given-names>S</given-names></name><name><surname>Wainscott</surname><given-names>DB</given-names></name><name><surname>Showalter</surname><given-names>AD</given-names></name><name><surname>Droz</surname><given-names>BA</given-names></name><name><surname>Kobilka</surname><given-names>TS</given-names></name><name><surname>Coghlan</surname><given-names>MP</given-names></name><name><surname>Willard</surname><given-names>FS</given-names></name><name><surname>Kawabe</surname><given-names>Y</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name><name><surname>Sloop</surname><given-names>KW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist</article-title><source>PNAS</source><volume>117</volume><fpage>29959</fpage><lpage>29967</lpage><pub-id pub-id-type="doi">10.1073/pnas.2014879117</pub-id><pub-id pub-id-type="pmid">33177239</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaya</surname><given-names>AI</given-names></name><name><surname>Lokits</surname><given-names>AD</given-names></name><name><surname>Gilbert</surname><given-names>JA</given-names></name><name><surname>Iverson</surname><given-names>TM</given-names></name><name><surname>Meiler</surname><given-names>J</given-names></name><name><surname>Hamm</surname><given-names>HE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A conserved hydrophobic core in Gαi1 regulates G protein activation and release from activated receptor</article-title><source>The Journal of Biological Chemistry</source><volume>291</volume><fpage>19674</fpage><lpage>19686</lpage><pub-id pub-id-type="doi">10.1074/jbc.M116.745513</pub-id><pub-id pub-id-type="pmid">27462082</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kokh</surname><given-names>DB</given-names></name><name><surname>Kaufmann</surname><given-names>T</given-names></name><name><surname>Kister</surname><given-names>B</given-names></name><name><surname>Wade</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Machine learning analysis of τRAMD trajectories to decipher molecular determinants of drug-target residence times</article-title><source>Frontiers in Molecular Biosciences</source><volume>6</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2019.00036</pub-id><pub-id pub-id-type="pmid">31179286</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kräutler</surname><given-names>V</given-names></name><name><surname>van Gunsteren</surname><given-names>WF</given-names></name><name><surname>Hünenberger</surname><given-names>PH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations</article-title><source>Journal of Computational Chemistry</source><volume>22</volume><fpage>501</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1002/1096-987X(20010415)22:5&lt;501::AID-JCC1021&gt;3.0.CO;2-V</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Lin</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The full activation mechanism of the adenosine A<sub>1</sub> receptor revealed by GaMD and Su-GaMD simulations</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2203702119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2203702119</pub-id><pub-id pub-id-type="pmid">36215480</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>YL</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name><name><surname>Fletcher</surname><given-names>MM</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Khoshouei</surname><given-names>M</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Koole</surname><given-names>C</given-names></name><name><surname>Furness</surname><given-names>SGB</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name><name><surname>Hay</surname><given-names>DL</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structure and dynamics of adrenomedullin receptors AM<sub>1</sub> and AM<sub>2</sub> reveal key mechanisms in the control of receptor phenotype by receptor activity-modifying proteins</article-title><source>ACS Pharmacology &amp; Translational Science</source><volume>3</volume><fpage>263</fpage><lpage>284</lpage><pub-id pub-id-type="doi">10.1021/acsptsci.9b00080</pub-id><pub-id pub-id-type="pmid">32296767</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linder</surname><given-names>ME</given-names></name><name><surname>Middleton</surname><given-names>P</given-names></name><name><surname>Hepler</surname><given-names>JR</given-names></name><name><surname>Taussig</surname><given-names>R</given-names></name><name><surname>Gilman</surname><given-names>AG</given-names></name><name><surname>Mumby</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Lipid modifications of G proteins: alpha subunits are palmitoylated</article-title><source>PNAS</source><volume>90</volume><fpage>3675</fpage><lpage>3679</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.8.3675</pub-id><pub-id pub-id-type="pmid">8475115</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Hilger</surname><given-names>D</given-names></name><name><surname>Aschauer</surname><given-names>P</given-names></name><name><surname>Tiemann</surname><given-names>JKS</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hirata</surname><given-names>K</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Guixà-González</surname><given-names>R</given-names></name><name><surname>Mathiesen</surname><given-names>JM</given-names></name><name><surname>Hildebrand</surname><given-names>PW</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Structural insights into the process of GPCR-G Protein Complex Formation</article-title><source>Cell</source><volume>177</volume><fpage>1243</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.04.021</pub-id><pub-id pub-id-type="pmid">31080070</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lomize</surname><given-names>MA</given-names></name><name><surname>Lomize</surname><given-names>AL</given-names></name><name><surname>Pogozheva</surname><given-names>ID</given-names></name><name><surname>Mosberg</surname><given-names>HI</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>OPM: orientations of proteins in membranes database</article-title><source>Bioinformatics</source><volume>22</volume><fpage>623</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btk023</pub-id><pub-id pub-id-type="pmid">16397007</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loncharich</surname><given-names>RJ</given-names></name><name><surname>Brooks</surname><given-names>BR</given-names></name><name><surname>Pastor</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-acetylalanyl-N’-methylamide</article-title><source>Biopolymers</source><volume>32</volume><fpage>523</fpage><lpage>535</lpage><pub-id pub-id-type="doi">10.1002/bip.360320508</pub-id><pub-id pub-id-type="pmid">1515543</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lovera</surname><given-names>S</given-names></name><name><surname>Cuzzolin</surname><given-names>A</given-names></name><name><surname>Kelm</surname><given-names>S</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name><name><surname>Sands</surname><given-names>ZA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Reconstruction of apo A2A receptor activation pathways reveal ligand-competent intermediates and state-dependent cholesterol hotspots</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>14199</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-50752-6</pub-id><pub-id pub-id-type="pmid">31578448</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Yuan</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>HE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Structural insights into the activation of GLP-1R by a small molecule agonist</article-title><source>Cell Research</source><volume>30</volume><fpage>1140</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1038/s41422-020-0384-8</pub-id><pub-id pub-id-type="pmid">32724086</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mafi</surname><given-names>A</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Goddard</surname><given-names>WA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The dynamics of agonist-β<sub>2</sub>-adrenergic receptor activation induced by binding of GDP-bound Gs protein</article-title><source>Nature Chemistry</source><volume>15</volume><fpage>1127</fpage><lpage>1137</lpage><pub-id pub-id-type="doi">10.1038/s41557-023-01238-6</pub-id><pub-id pub-id-type="pmid">37349378</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattedi</surname><given-names>G</given-names></name><name><surname>Acosta-Gutiérrez</surname><given-names>S</given-names></name><name><surname>Clark</surname><given-names>T</given-names></name><name><surname>Gervasio</surname><given-names>FL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A combined activation mechanism for the glucagon receptor</article-title><source>PNAS</source><volume>117</volume><fpage>15414</fpage><lpage>15422</lpage><pub-id pub-id-type="doi">10.1073/pnas.1921851117</pub-id><pub-id pub-id-type="pmid">32571939</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayne</surname><given-names>CG</given-names></name><name><surname>Saam</surname><given-names>J</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name><name><surname>Tajkhorshid</surname><given-names>E</given-names></name><name><surname>Gumbart</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Rapid parameterization of small molecules using the force field toolkit</article-title><source>Journal of Computational Chemistry</source><volume>34</volume><fpage>2757</fpage><lpage>2770</lpage><pub-id pub-id-type="doi">10.1002/jcc.23422</pub-id><pub-id pub-id-type="pmid">24000174</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGibbon</surname><given-names>RT</given-names></name><name><surname>Beauchamp</surname><given-names>KA</given-names></name><name><surname>Harrigan</surname><given-names>MP</given-names></name><name><surname>Klein</surname><given-names>C</given-names></name><name><surname>Swails</surname><given-names>JM</given-names></name><name><surname>Hernández</surname><given-names>CX</given-names></name><name><surname>Schwantes</surname><given-names>CR</given-names></name><name><surname>Wang</surname><given-names>LP</given-names></name><name><surname>Lane</surname><given-names>TJ</given-names></name><name><surname>Pande</surname><given-names>VS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>MDTraj: a modern open library for the analysis of molecular dynamics trajectories</article-title><source>Biophysical Journal</source><volume>109</volume><fpage>1528</fpage><lpage>1532</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2015.08.015</pub-id><pub-id pub-id-type="pmid">26488642</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>Feher</surname><given-names>VA</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gaussian accelerated molecular dynamics: unconstrained enhanced sampling and free energy calculation</article-title><source>Journal of Chemical Theory and Computation</source><volume>11</volume><fpage>3584</fpage><lpage>3595</lpage><pub-id pub-id-type="doi">10.1021/acs.jctc.5b00436</pub-id><pub-id pub-id-type="pmid">26300708</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miao</surname><given-names>Y</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mechanism of the G-protein mimetic nanobody binding to a muscarinic G-protein-coupled receptor</article-title><source>PNAS</source><volume>115</volume><fpage>3036</fpage><lpage>3041</lpage><pub-id pub-id-type="doi">10.1073/pnas.1800756115</pub-id><pub-id pub-id-type="pmid">29507218</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michaud-Agrawal</surname><given-names>N</given-names></name><name><surname>Denning</surname><given-names>EJ</given-names></name><name><surname>Woolf</surname><given-names>TB</given-names></name><name><surname>Beckstein</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>MDAnalysis: a toolkit for the analysis of molecular dynamics simulations</article-title><source>Journal of Computational Chemistry</source><volume>32</volume><fpage>2319</fpage><lpage>2327</lpage><pub-id pub-id-type="doi">10.1002/jcc.21787</pub-id><pub-id pub-id-type="pmid">21500218</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>BR</given-names><suffix>III</suffix></name><name><surname>McGee</surname><given-names>TD</given-names></name><name><surname>Swails</surname><given-names>JM</given-names></name><name><surname>Homeyer</surname><given-names>N</given-names></name><name><surname>Gohlke</surname><given-names>H</given-names></name><name><surname>Roitberg</surname><given-names>AE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>MMPBSA.py: an efficient program for end-state free energy calculations</article-title><source>Journal of Chemical Theory and Computation</source><volume>8</volume><fpage>3314</fpage><lpage>3321</lpage><pub-id pub-id-type="doi">10.1021/ct300418h</pub-id><pub-id pub-id-type="pmid">26605738</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mystek</surname><given-names>P</given-names></name><name><surname>Rysiewicz</surname><given-names>B</given-names></name><name><surname>Gregrowicz</surname><given-names>J</given-names></name><name><surname>Dziedzicka-Wasylewska</surname><given-names>M</given-names></name><name><surname>Polit</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gγ and Gα identity dictate a G-protein heterotrimer plasma membrane targeting</article-title><source>Cells</source><volume>8</volume><elocation-id>1246</elocation-id><pub-id pub-id-type="doi">10.3390/cells8101246</pub-id><pub-id pub-id-type="pmid">31614907</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>MHM</given-names></name><name><surname>Søndergaard</surname><given-names>CR</given-names></name><name><surname>Rostkowski</surname><given-names>M</given-names></name><name><surname>Jensen</surname><given-names>JH</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>PROPKA3: consistent treatment of internal and surface residues in empirical pKa predictions</article-title><source>Journal of Chemical Theory and Computation</source><volume>7</volume><fpage>525</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1021/ct100578z</pub-id><pub-id pub-id-type="pmid">26596171</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez</surname><given-names>A</given-names></name><name><surname>Martínez-Rosell</surname><given-names>G</given-names></name><name><surname>De Fabritiis</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Simulations meet machine learning in structural biology</article-title><source>Current Opinion in Structural Biology</source><volume>49</volume><fpage>139</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.sbi.2018.02.004</pub-id><pub-id pub-id-type="pmid">29477048</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Greenblatt</surname><given-names>DM</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>UCSF Chimera--A visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>JC</given-names></name><name><surname>Braun</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Gumbart</surname><given-names>J</given-names></name><name><surname>Tajkhorshid</surname><given-names>E</given-names></name><name><surname>Villa</surname><given-names>E</given-names></name><name><surname>Chipot</surname><given-names>C</given-names></name><name><surname>Skeel</surname><given-names>RD</given-names></name><name><surname>Kalé</surname><given-names>L</given-names></name><name><surname>Schulten</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Scalable molecular dynamics with NAMD</article-title><source>Journal of Computational Chemistry</source><volume>26</volume><fpage>1781</fpage><lpage>1802</lpage><pub-id pub-id-type="doi">10.1002/jcc.20289</pub-id><pub-id pub-id-type="pmid">16222654</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Pipitò</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2025">2025</year><data-title>mwSuMD - Molecular Dynamics Supervision Tool</data-title><version designator="swh:1:rev:b5cd2dacea7b003df96ee88a34919d87b937b744">swh:1:rev:b5cd2dacea7b003df96ee88a34919d87b937b744</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:3a780e7322852c01cf6ca71a61a2b161b5ccda6c;origin=https://github.com/pipitoludovico/mwSuMD_multiEngine;visit=swh:1:snp:17cec8ea7b03cfd8e5c4cfddc542c49b3796d350;anchor=swh:1:rev:b5cd2dacea7b003df96ee88a34919d87b937b744">https://archive.softwareheritage.org/swh:1:dir:3a780e7322852c01cf6ca71a61a2b161b5ccda6c;origin=https://github.com/pipitoludovico/mwSuMD_multiEngine;visit=swh:1:snp:17cec8ea7b03cfd8e5c4cfddc542c49b3796d350;anchor=swh:1:rev:b5cd2dacea7b003df96ee88a34919d87b937b744</ext-link></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>SGF</given-names></name><name><surname>DeVree</surname><given-names>BT</given-names></name><name><surname>Zou</surname><given-names>Y</given-names></name><name><surname>Kruse</surname><given-names>AC</given-names></name><name><surname>Chung</surname><given-names>KY</given-names></name><name><surname>Kobilka</surname><given-names>TS</given-names></name><name><surname>Thian</surname><given-names>FS</given-names></name><name><surname>Chae</surname><given-names>PS</given-names></name><name><surname>Pardon</surname><given-names>E</given-names></name><name><surname>Calinski</surname><given-names>D</given-names></name><name><surname>Mathiesen</surname><given-names>JM</given-names></name><name><surname>Shah</surname><given-names>STA</given-names></name><name><surname>Lyons</surname><given-names>JA</given-names></name><name><surname>Caffrey</surname><given-names>M</given-names></name><name><surname>Gellman</surname><given-names>SH</given-names></name><name><surname>Steyaert</surname><given-names>J</given-names></name><name><surname>Skiniotis</surname><given-names>G</given-names></name><name><surname>Weis</surname><given-names>WI</given-names></name><name><surname>Sunahara</surname><given-names>RK</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Crystal structure of the β2 adrenergic receptor-Gs protein complex</article-title><source>Nature</source><volume>477</volume><fpage>549</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1038/nature10361</pub-id><pub-id pub-id-type="pmid">21772288</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ring</surname><given-names>AM</given-names></name><name><surname>Manglik</surname><given-names>A</given-names></name><name><surname>Kruse</surname><given-names>AC</given-names></name><name><surname>Enos</surname><given-names>MD</given-names></name><name><surname>Weis</surname><given-names>WI</given-names></name><name><surname>Garcia</surname><given-names>KC</given-names></name><name><surname>Kobilka</surname><given-names>BK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody</article-title><source>Nature</source><volume>502</volume><fpage>575</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1038/nature12572</pub-id><pub-id pub-id-type="pmid">24056936</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabbadin</surname><given-names>D</given-names></name><name><surname>Moro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale</article-title><source>Journal of Chemical Information and Modeling</source><volume>54</volume><fpage>372</fpage><lpage>376</lpage><pub-id pub-id-type="doi">10.1021/ci400766b</pub-id><pub-id pub-id-type="pmid">24456045</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salmaso</surname><given-names>V</given-names></name><name><surname>Sturlese</surname><given-names>M</given-names></name><name><surname>Cuzzolin</surname><given-names>A</given-names></name><name><surname>Moro</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Exploring protein-peptide recognition pathways using a supervised molecular dynamics approach</article-title><source>Structure</source><volume>25</volume><fpage>655</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1016/j.str.2017.02.009</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schiöth</surname><given-names>HB</given-names></name><name><surname>Fredriksson</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The GRAFS classification system of G-protein coupled receptors in comparative perspective</article-title><source>General and Comparative Endocrinology</source><volume>142</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1016/j.ygcen.2004.12.018</pub-id><pub-id pub-id-type="pmid">15862553</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Membrane packing problems: a short review on computational membrane modeling methods and tools</article-title><source>Computational and Structural Biotechnology Journal</source><volume>5</volume><elocation-id>e201302014</elocation-id><pub-id pub-id-type="doi">10.5936/csbj.201302014</pub-id><pub-id pub-id-type="pmid">24688707</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sriram</surname><given-names>K</given-names></name><name><surname>Insel</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs?</article-title><source>Molecular Pharmacology</source><volume>93</volume><fpage>251</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1124/mol.117.111062</pub-id><pub-id pub-id-type="pmid">29298813</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stanley</surname><given-names>N</given-names></name><name><surname>Pardo</surname><given-names>L</given-names></name><name><surname>Fabritiis</surname><given-names>GD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The pathway of ligand entry from the membrane bilayer to a lipid G protein-coupled receptor</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>22639</elocation-id><pub-id pub-id-type="doi">10.1038/srep22639</pub-id><pub-id pub-id-type="pmid">26940769</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugita</surname><given-names>Y</given-names></name><name><surname>Okamoto</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Replica-exchange molecular dynamics method for protein folding</article-title><source>Chemical Physics Letters</source><volume>314</volume><fpage>141</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1016/S0009-2614(99)01123-9</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Blumer</surname><given-names>KJ</given-names></name><name><surname>Bowman</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Simulation of spontaneous G protein activation reveals a new intermediate driving GDP unbinding</article-title><source>eLife</source><volume>7</volume><elocation-id>e38465</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.38465</pub-id><pub-id pub-id-type="pmid">30289386</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syrovatkina</surname><given-names>V</given-names></name><name><surname>Alegre</surname><given-names>KO</given-names></name><name><surname>Dey</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulation, signaling, and physiological functions of G-proteins</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>3850</fpage><lpage>3868</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2016.08.002</pub-id><pub-id pub-id-type="pmid">27515397</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>McCorvy</surname><given-names>JD</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Biased ligands of G protein-coupled receptors (GPCRs): structure–functional selectivity relationships (SFSRs) and therapeutic potential</article-title><source>Journal of Medicinal Chemistry</source><volume>61</volume><fpage>9841</fpage><lpage>9878</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.8b00435</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanommeslaeghe</surname><given-names>K</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Automation of the CHARMM general force field (CGenFF) I: bond perception and atom typing</article-title><source>Journal of Chemical Information and Modeling</source><volume>52</volume><fpage>3144</fpage><lpage>3154</lpage><pub-id pub-id-type="doi">10.1021/ci300363c</pub-id><pub-id pub-id-type="pmid">23146088</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanommeslaeghe</surname><given-names>K</given-names></name><name><surname>Raman</surname><given-names>EP</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Automation of the CHARMM general force field (CGenFF) II: assignment of bonded parameters and partial atomic charges</article-title><source>Journal of Chemical Information and Modeling</source><volume>52</volume><fpage>3155</fpage><lpage>3168</lpage><pub-id pub-id-type="doi">10.1021/ci3003649</pub-id><pub-id pub-id-type="pmid">23145473</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wall</surname><given-names>MJ</given-names></name><name><surname>Hill</surname><given-names>E</given-names></name><name><surname>Huckstepp</surname><given-names>R</given-names></name><name><surname>Barkan</surname><given-names>K</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Leuenberger</surname><given-names>M</given-names></name><name><surname>Preti</surname><given-names>B</given-names></name><name><surname>Winfield</surname><given-names>I</given-names></name><name><surname>Carvalho</surname><given-names>S</given-names></name><name><surname>Suchankova</surname><given-names>A</given-names></name><name><surname>Wei</surname><given-names>H</given-names></name><name><surname>Safitri</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Imlach</surname><given-names>W</given-names></name><name><surname>La Mache</surname><given-names>C</given-names></name><name><surname>Dean</surname><given-names>E</given-names></name><name><surname>Hume</surname><given-names>C</given-names></name><name><surname>Hayward</surname><given-names>S</given-names></name><name><surname>Oliver</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>F-Y</given-names></name><name><surname>Spanswick</surname><given-names>D</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Lochner</surname><given-names>M</given-names></name><name><surname>Ladds</surname><given-names>G</given-names></name><name><surname>Frenguelli</surname><given-names>BG</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Selective activation of Gαob by an adenosine A<sub>1</sub> receptor agonist elicits analgesia without cardiorespiratory depression</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>4150</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-31652-2</pub-id><pub-id pub-id-type="pmid">35851064</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>JZH</given-names></name><name><surname>Hou</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design</article-title><source>Chemical Reviews</source><volume>119</volume><fpage>9478</fpage><lpage>9508</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.9b00055</pub-id><pub-id pub-id-type="pmid">31244000</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woods</surname><given-names>RJ</given-names></name><name><surname>Chappelle</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Restrained electrostatic potential atomic partial charges for condensed-phase simulations of carbohydrates</article-title><source>Theochem</source><volume>527</volume><fpage>149</fpage><lpage>156</lpage><pub-id pub-id-type="doi">10.1016/S0166-1280(00)00487-5</pub-id><pub-id pub-id-type="pmid">25309012</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Simms</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Polar transmembrane interactions drive formation of ligand-specific and signal pathway-biased family B G protein-coupled receptor conformations</article-title><source>PNAS</source><volume>110</volume><fpage>5211</fpage><lpage>5216</lpage><pub-id pub-id-type="doi">10.1073/pnas.1221585110</pub-id><pub-id pub-id-type="pmid">23479653</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Koole</surname><given-names>C</given-names></name><name><surname>Smith</surname><given-names>KJ</given-names></name><name><surname>Mobarec</surname><given-names>JC</given-names></name><name><surname>Simms</surname><given-names>J</given-names></name><name><surname>Quon</surname><given-names>T</given-names></name><name><surname>Coudrat</surname><given-names>T</given-names></name><name><surname>Furness</surname><given-names>SGB</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A hydrogen-bonded polar network in the core of the glucagon-like peptide-1 receptor is a fulcrum for biased agonism: lessons from class B crystal structures</article-title><source>Molecular Pharmacology</source><volume>89</volume><fpage>335</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1124/mol.115.101246</pub-id><pub-id pub-id-type="pmid">26700562</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Hang</surname><given-names>K</given-names></name><name><surname>Laursen</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Han</surname><given-names>GW</given-names></name><name><surname>Ren</surname><given-names>Q</given-names></name><name><surname>Roed</surname><given-names>NK</given-names></name><name><surname>Lin</surname><given-names>G</given-names></name><name><surname>Hanson</surname><given-names>MA</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name><name><surname>Reedtz-Runge</surname><given-names>S</given-names></name><name><surname>Song</surname><given-names>G</given-names></name><name><surname>Stevens</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Full-length human GLP-1 receptor structure without orthosteric ligands</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>1272</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14934-5</pub-id><pub-id pub-id-type="pmid">32152292</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Vanommeslaeghe</surname><given-names>K</given-names></name><name><surname>MacKerell</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations</article-title><source>Journal of Computational Chemistry</source><volume>33</volume><fpage>2451</fpage><lpage>2468</lpage><pub-id pub-id-type="doi">10.1002/jcc.23067</pub-id><pub-id pub-id-type="pmid">22821581</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>S</given-names></name><name><surname>Xia</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Pan</surname><given-names>C</given-names></name><name><surname>Fan</surname><given-names>Z</given-names></name><name><surname>Lei</surname><given-names>X</given-names></name><name><surname>Stevens</surname><given-names>RC</given-names></name><name><surname>Sali</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Shui</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Conformational dynamics of the activated GLP-1 receptor-G<sub>s</sub> complex revealed by cross-linking mass spectrometry and integrative structure modeling</article-title><source>ACS Central Science</source><volume>9</volume><fpage>992</fpage><lpage>1007</lpage><pub-id pub-id-type="doi">10.1021/acscentsci.3c00063</pub-id><pub-id pub-id-type="pmid">37252352</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Melia</surname><given-names>TJ</given-names></name><name><surname>He</surname><given-names>F</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>McGough</surname><given-names>A</given-names></name><name><surname>Schmid</surname><given-names>MF</given-names></name><name><surname>Wensel</surname><given-names>TG</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>How a G protein binds a membrane</article-title><source>Journal of Biological Chemistry</source><volume>279</volume><fpage>33937</fpage><lpage>33945</lpage><pub-id pub-id-type="doi">10.1074/jbc.M403404200</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Kooistra</surname><given-names>AJ</given-names></name><name><surname>Truong</surname><given-names>TT</given-names></name><name><surname>Ang</surname><given-names>SY</given-names></name><name><surname>Underwood</surname><given-names>CR</given-names></name><name><surname>Egebjerg</surname><given-names>T</given-names></name><name><surname>Šenel</surname><given-names>P</given-names></name><name><surname>Stewart</surname><given-names>GD</given-names></name><name><surname>Liang</surname><given-names>YL</given-names></name><name><surname>Glukhova</surname><given-names>A</given-names></name><name><surname>Venugopal</surname><given-names>H</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Furness</surname><given-names>SGB</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name><name><surname>Reedtz-Runge</surname><given-names>S</given-names></name><name><surname>Langmead</surname><given-names>CJ</given-names></name><name><surname>Gloriam</surname><given-names>DE</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Differential GLP-1R binding and activation by peptide and non-peptide agonists</article-title><source>Molecular Cell</source><volume>80</volume><fpage>485</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2020.09.020</pub-id><pub-id pub-id-type="pmid">33027691</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Johnson</surname><given-names>RM</given-names></name><name><surname>Drulyte</surname><given-names>I</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Kotecha</surname><given-names>A</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Evolving cryo-EM structural approaches for GPCR drug discovery</article-title><source>Structure</source><volume>29</volume><fpage>963</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/j.str.2021.04.008</pub-id><pub-id pub-id-type="pmid">33957078</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>P</given-names></name><name><surname>Liang</surname><given-names>YL</given-names></name><name><surname>Belousoff</surname><given-names>MJ</given-names></name><name><surname>Deganutti</surname><given-names>G</given-names></name><name><surname>Fletcher</surname><given-names>MM</given-names></name><name><surname>Willard</surname><given-names>FS</given-names></name><name><surname>Bell</surname><given-names>MG</given-names></name><name><surname>Christe</surname><given-names>ME</given-names></name><name><surname>Sloop</surname><given-names>KW</given-names></name><name><surname>Inoue</surname><given-names>A</given-names></name><name><surname>Truong</surname><given-names>TT</given-names></name><name><surname>Clydesdale</surname><given-names>L</given-names></name><name><surname>Furness</surname><given-names>SGB</given-names></name><name><surname>Christopoulos</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name><name><surname>Miller</surname><given-names>LJ</given-names></name><name><surname>Reynolds</surname><given-names>CA</given-names></name><name><surname>Danev</surname><given-names>R</given-names></name><name><surname>Sexton</surname><given-names>PM</given-names></name><name><surname>Wootten</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Activation of the GLP-1 receptor by a non-peptidic agonist</article-title><source>Nature</source><volume>577</volume><fpage>432</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1902-z</pub-id><pub-id pub-id-type="pmid">31915381</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><name><surname>Yin</surname><given-names>W</given-names></name><name><surname>Croll</surname><given-names>TI</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>HE</given-names></name><name><surname>Wang</surname><given-names>MW</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Molecular basis of ligand recognition and activation of human V2 vasopressin receptor</article-title><source>Cell Research</source><volume>31</volume><fpage>929</fpage><lpage>931</lpage><pub-id pub-id-type="doi">10.1038/s41422-021-00480-2</pub-id><pub-id pub-id-type="pmid">33742150</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuckerman</surname><given-names>DM</given-names></name><name><surname>Chong</surname><given-names>LT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Weighted ensemble simulation: review of methodology, applications, and software</article-title><source>Annual Review of Biophysics</source><volume>46</volume><fpage>43</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1146/annurev-biophys-070816-033834</pub-id><pub-id pub-id-type="pmid">28301772</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>GLP-1R:G<sub>s</sub> contacts during multiple walker supervised molecular dynamics (mwSuMD) G<sub>s</sub> binding simulations.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">GLP-1R residue</th><th align="left" valign="bottom">G<sub>s</sub> residue</th><th align="left" valign="bottom">Occupancy (% MD frames)</th></tr></thead><tbody><tr><td align="left" valign="bottom">ASP344 (6.33)</td><td align="left" valign="bottom">ARG385</td><td align="left" valign="bottom">87.7</td></tr><tr><td align="left" valign="bottom">ARG348 (6.37)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">83</td></tr><tr><td align="left" valign="bottom">GLU408 (7.63)</td><td align="left" valign="bottom">ARG356</td><td align="left" valign="bottom">64.4</td></tr><tr><td align="left" valign="bottom">LEU254 (3.57)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">58.1</td></tr><tr><td align="left" valign="bottom">ARG419 (7.83)</td><td align="left" valign="bottom">ASP312</td><td align="left" valign="bottom">55.3</td></tr><tr><td align="left" valign="bottom">LYS415 (7.70)</td><td align="left" valign="bottom">ASP312</td><td align="left" valign="bottom">47.6</td></tr><tr><td align="left" valign="bottom">TYR250 (3.53)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">46.3</td></tr><tr><td align="left" valign="bottom">LEU254 (3.57)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">43.7</td></tr><tr><td align="left" valign="bottom">ARG419 (7.83)</td><td align="left" valign="bottom">HIS311</td><td align="left" valign="bottom">43.2</td></tr><tr><td align="left" valign="bottom">LEU254 (3.57)</td><td align="left" valign="bottom">LEU388</td><td align="left" valign="bottom">42.4</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">ARG38</td><td align="left" valign="bottom">39.4</td></tr><tr><td align="left" valign="bottom">SER352 (6.41)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">37.4</td></tr><tr><td align="left" valign="bottom">LYS351 (6.40)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">36</td></tr><tr><td align="left" valign="bottom">PHE257 (3.60)</td><td align="left" valign="bottom">GLN384</td><td align="left" valign="bottom">35.2</td></tr><tr><td align="left" valign="bottom">GLU262 (4.38)</td><td align="left" valign="bottom">ARG38</td><td align="left" valign="bottom">35</td></tr><tr><td align="left" valign="bottom">ARG348 (6.37)</td><td align="left" valign="bottom">ARG385</td><td align="left" valign="bottom">30.8</td></tr><tr><td align="left" valign="bottom">ARG348 (6.37)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">30.6</td></tr><tr><td align="left" valign="bottom">LEU251 (3.54)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">29.4</td></tr><tr><td align="left" valign="bottom">ILE345 (6.34)</td><td align="left" valign="bottom">ARG385</td><td align="left" valign="bottom">23.8</td></tr><tr><td align="left" valign="bottom">LEU349 (6.38)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">23.2</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">ASP312</td><td align="left" valign="bottom">22.3</td></tr><tr><td align="left" valign="bottom">LYS342 (6.31)</td><td align="left" valign="bottom">ASP323</td><td align="left" valign="bottom">21.6</td></tr><tr><td align="left" valign="bottom">PHE260 (ICL2)</td><td align="left" valign="bottom">ARG38</td><td align="left" valign="bottom">21.5</td></tr><tr><td align="left" valign="bottom">LEU254 (3.57)</td><td align="left" valign="bottom">GLN384</td><td align="left" valign="bottom">20.6</td></tr><tr><td align="left" valign="bottom">ILE345 (6.34)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">19.9</td></tr><tr><td align="left" valign="bottom">GLU262 (4.38)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">19,7</td></tr><tr><td align="left" valign="bottom">SER261 (ICL2)</td><td align="left" valign="bottom">GLN35</td><td align="left" valign="bottom">19.7</td></tr><tr><td align="left" valign="bottom">ARG348 (6.37)</td><td align="left" valign="bottom">ARG389</td><td align="left" valign="bottom">18.8</td></tr><tr><td align="left" valign="bottom">LEU254 (3.57)</td><td align="left" valign="bottom">HIS387</td><td align="left" valign="bottom">18.6</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">ASN313</td><td align="left" valign="bottom">17.6</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">HIS387</td><td align="left" valign="bottom">16.8</td></tr><tr><td align="left" valign="bottom">SER352 (6.41)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">16.7</td></tr><tr><td align="left" valign="bottom">PHE257 (3.60)</td><td align="left" valign="bottom">HIS387</td><td align="left" valign="bottom">16.3</td></tr><tr><td align="left" valign="bottom">LYS351 (6.40)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">16.3</td></tr><tr><td align="left" valign="bottom">TYR250 (3.53)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">15.7</td></tr><tr><td align="left" valign="bottom">LEU255 (3.58)</td><td align="left" valign="bottom">GLN384</td><td align="left" valign="bottom">15.6</td></tr><tr><td align="left" valign="bottom">GLU412 (7.67)</td><td align="left" valign="bottom">ARG356</td><td align="left" valign="bottom">15</td></tr><tr><td align="left" valign="bottom">LYS415 (7.70)</td><td align="left" valign="bottom">ASP354</td><td align="left" valign="bottom">14</td></tr><tr><td align="left" valign="bottom">HIS173 (ICL1)</td><td align="left" valign="bottom">PHE335</td><td align="left" valign="bottom">13.9</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">GLN35</td><td align="left" valign="bottom">13.8</td></tr><tr><td align="left" valign="bottom">PHE257 (3.60)</td><td align="left" valign="bottom">LEU388</td><td align="left" valign="bottom">13.6</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">ASP333</td><td align="left" valign="bottom">13.5</td></tr><tr><td align="left" valign="bottom">SER258 (ICL2)</td><td align="left" valign="bottom">HIS387</td><td align="left" valign="bottom">13.1</td></tr><tr><td align="left" valign="bottom">SER261 (ICL2)</td><td align="left" valign="bottom">ARG38</td><td align="left" valign="bottom">12.9</td></tr><tr><td align="left" valign="bottom">ASN407 (7.62)</td><td align="left" valign="bottom">ARG356</td><td align="left" valign="bottom">12.5</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">12.4</td></tr><tr><td align="left" valign="bottom">ARG170 (ICL1)</td><td align="left" valign="bottom">ASP312</td><td align="left" valign="bottom">12.3</td></tr><tr><td align="left" valign="bottom">LEU255 (3.58)</td><td align="left" valign="bottom">LEU388</td><td align="left" valign="bottom">11.6</td></tr><tr><td align="left" valign="bottom">LEU411 (7.66)</td><td align="left" valign="bottom">ARG356</td><td align="left" valign="bottom">11.5</td></tr><tr><td align="left" valign="bottom">ARG176 (2.46)</td><td align="left" valign="bottom">GLU392</td><td align="left" valign="bottom">11.5</td></tr><tr><td align="left" valign="bottom">GLN263 (4.39)</td><td align="left" valign="bottom">TRP332</td><td align="left" valign="bottom">11.5</td></tr><tr><td align="left" valign="bottom">ILE345 (6.34)</td><td align="left" valign="bottom">LEU388</td><td align="left" valign="bottom">11.3</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">ARG314</td><td align="left" valign="bottom">11.2</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">ALA39</td><td align="left" valign="bottom">10.7</td></tr><tr><td align="left" valign="bottom">TRP264 (4.40)</td><td align="left" valign="bottom">PHE335</td><td align="left" valign="bottom">10.5</td></tr><tr><td align="left" valign="bottom">ARG267 (4.43)</td><td align="left" valign="bottom">ASP333</td><td align="left" valign="bottom">10.5</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">TRP332</td><td align="left" valign="bottom">10.5</td></tr><tr><td align="left" valign="bottom">PHE257 (3.60)</td><td align="left" valign="bottom">ARG38</td><td align="left" valign="bottom">10.2</td></tr><tr><td align="left" valign="bottom">LEU349 (6.38)</td><td align="left" valign="bottom">LEU393</td><td align="left" valign="bottom">10</td></tr><tr><td align="left" valign="bottom">GLN263 (4.39)</td><td align="left" valign="bottom">ASP333</td><td align="left" valign="bottom">10</td></tr><tr><td align="left" valign="bottom">GLN263 (4.39)</td><td align="left" valign="bottom">ASN313</td><td align="left" valign="bottom">9.9</td></tr><tr><td align="left" valign="bottom">ARG419 (7.83)</td><td align="left" valign="bottom">ASP354</td><td align="left" valign="bottom">9.7</td></tr><tr><td align="left" valign="bottom">THR343 (6.32)</td><td align="left" valign="bottom">ARG385</td><td align="left" valign="bottom">9.1</td></tr><tr><td align="left" valign="bottom">SER258 (ICL2)</td><td align="left" valign="bottom">ARG38</td><td align="left" valign="bottom">9</td></tr><tr><td align="left" valign="bottom">LYS342 (6.31)</td><td align="left" valign="bottom">GLU322</td><td align="left" valign="bottom">8.7</td></tr><tr><td align="left" valign="bottom">SER261 (ICL2)</td><td align="left" valign="bottom">ASP333</td><td align="left" valign="bottom">8.6</td></tr><tr><td align="left" valign="bottom">LEU255 (3.58)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">8.6</td></tr><tr><td align="left" valign="bottom">PHE260 (ICL2)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">8.5</td></tr><tr><td align="left" valign="bottom">ASN406 (7.61)</td><td align="left" valign="bottom">GLU392</td><td align="left" valign="bottom">8.4</td></tr><tr><td align="left" valign="bottom">SER258 (ICL2)</td><td align="left" valign="bottom">HIS41</td><td align="left" valign="bottom">8.4</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">ARG337</td><td align="left" valign="bottom">8.4</td></tr><tr><td align="left" valign="bottom">SER258 (ICL2)</td><td align="left" valign="bottom">GLN384</td><td align="left" valign="bottom">8.1</td></tr><tr><td align="left" valign="bottom">ARG348 (6.37)</td><td align="left" valign="bottom">LEU388</td><td align="left" valign="bottom">7.9</td></tr><tr><td align="left" valign="bottom">ARG267 (4.43)</td><td align="left" valign="bottom">ASN313</td><td align="left" valign="bottom">7.9</td></tr><tr><td align="left" valign="bottom">HIS173 (ICL1)</td><td align="left" valign="bottom">ARG337</td><td align="left" valign="bottom">7.8</td></tr><tr><td align="left" valign="bottom">PHE260 (ICL2)</td><td align="left" valign="bottom">GLN35</td><td align="left" valign="bottom">7.4</td></tr><tr><td align="left" valign="bottom">ARG176 (2.46)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">7.3</td></tr><tr><td align="left" valign="bottom">ARG267 (4.43)</td><td align="left" valign="bottom">PHE335</td><td align="left" valign="bottom">7.2</td></tr><tr><td align="left" valign="bottom">ALA256 (3.59)</td><td align="left" valign="bottom">GLN384</td><td align="left" valign="bottom">7</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">HIS41</td><td align="left" valign="bottom">7</td></tr><tr><td align="left" valign="bottom">CYS174 (2.44)</td><td align="left" valign="bottom">ARG356</td><td align="left" valign="bottom">6.5</td></tr><tr><td align="left" valign="bottom">GLU408 (7.63)</td><td align="left" valign="bottom">GLU392</td><td align="left" valign="bottom">6.1</td></tr><tr><td align="left" valign="bottom">PHE257 (3.60)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">6.1</td></tr><tr><td align="left" valign="bottom">SER261 (ICL2)</td><td align="left" valign="bottom">LYS34</td><td align="left" valign="bottom">6</td></tr><tr><td align="left" valign="bottom">HIS173 (ICL1)</td><td align="left" valign="bottom">ARG314</td><td align="left" valign="bottom">6</td></tr><tr><td align="left" valign="bottom">LEU251 (3.54)</td><td align="left" valign="bottom">LEU388</td><td align="left" valign="bottom">6</td></tr><tr><td align="left" valign="bottom">HIS173 (ICL1)</td><td align="left" valign="bottom">ASP312</td><td align="left" valign="bottom">5.9</td></tr><tr><td align="left" valign="bottom">HIS173 (ICL1)</td><td align="left" valign="bottom">TRP332</td><td align="left" valign="bottom">5.9</td></tr><tr><td align="left" valign="bottom">VAL259 (ICL2)</td><td align="left" valign="bottom">LEU55</td><td align="left" valign="bottom">5.9</td></tr><tr><td align="left" valign="bottom">ASN407 (7.62)</td><td align="left" valign="bottom">ARG389</td><td align="left" valign="bottom">5.8</td></tr><tr><td align="left" valign="bottom">HIS171 (ICL1)</td><td align="left" valign="bottom">GLY310</td><td align="left" valign="bottom">5.8</td></tr><tr><td align="left" valign="bottom">TYR178 (2.48)</td><td align="left" valign="bottom">ASP312</td><td align="left" valign="bottom">5.7</td></tr><tr><td align="left" valign="bottom">SER258 (ICL2)</td><td align="left" valign="bottom">VAL217</td><td align="left" valign="bottom">5.7</td></tr><tr><td align="left" valign="bottom">SER261 (ICL2)</td><td align="left" valign="bottom">GLN31</td><td align="left" valign="bottom">5.7</td></tr><tr><td align="left" valign="bottom">LYS342 (6.31)</td><td align="left" valign="bottom">THR325</td><td align="left" valign="bottom">5.6</td></tr><tr><td align="left" valign="bottom">LYS342 (6.31)</td><td align="left" valign="bottom">ALA324</td><td align="left" valign="bottom">5.5</td></tr><tr><td align="left" valign="bottom">LEU254 (3.57)</td><td align="left" valign="bottom">LEU394</td><td align="left" valign="bottom">5.4</td></tr><tr><td align="left" valign="bottom">CYS341 (6.30)</td><td align="left" valign="bottom">ASP323</td><td align="left" valign="bottom">5.4</td></tr><tr><td align="left" valign="bottom">TRP264 (4.40)</td><td align="left" valign="bottom">ARG52</td><td align="left" valign="bottom">5.3</td></tr><tr><td align="left" valign="bottom">GLU408 (7.63)</td><td align="left" valign="bottom">ARG389</td><td align="left" valign="bottom">5.2</td></tr><tr><td align="left" valign="bottom">SER258 (ICL2)</td><td align="left" valign="bottom">TYR391</td><td align="left" valign="bottom">5.1</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96513.4.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Allen</surname><given-names>Toby W</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>RMIT University</institution><country>Australia</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Useful</kwd></kwd-group></front-stub><body><p>This study describes an improved adaptive sampling approach, multiple-walker Supervised Molecular Dynamics (mwSuMD), and its application to G protein-coupled receptors (GPCRs), which are the most abundant membrane proteins and key targets for drug discovery. The manuscript provides <bold>solid</bold> evidence that the mwSuMD approach can assist in the sampling of complex binding processes, leading to <bold>useful</bold> findings for GPCR activity, including resolution of interactions not seen experimentally. The method has the potential to have broad applicability in structural biology and pharmacology.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96513.4.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors investigate ligand and protein-binding processes in GPCRs (including dimerization) by the multiple walker supervised molecular dynamics method. The paper is interesting and it is very well written.</p><p>Strengths:</p><p>The authors' method is a powerful tool to gain insight on the structural basis for the pharmacology of G protein-coupled receptors.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96513.4.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The study by Deganutti and co-workers is a methodological report on an adaptive sampling approach, multiple walker supervised molecular dynamics (mwSuMD), which represents an improved version of the previous SuMD.</p><p>Case-studies concern complex conformational transitions in a number of G protein Coupled Receptors (GPCRs) involving long time-scale motions such as binding-unbinding and collective motions of domains or portions. GPCRs are specialized GEFs (guanine nucleotide exchange factors) of heterotrimeric Gα proteins of the Ras GTPase superfamily. They constitute the largest superfamily of membrane proteins and are of central biomedical relevance as privileged targets of currently marketed drugs.</p><p>MwSuMD was exploited to address:</p><p>a) binding and unbinding of the arginine-vasopressin (AVP) cyclic peptide agonist to the V2 vasopressin receptor (V2R);</p><p>b) molecular recognition of the β2-adrenergic receptor (β2-AR) and heterotrimeric GDP-bound Gs protein;</p><p>c) molecular recognition of the A1-adenosine receptor (A1R) and palmotoylated and geranylgeranylated membrane-anchored heterotrimeric GDP-bound Gi protein;</p><p>d) the whole process of GDP release from membrane-anchored heterotrimeric Gs following interaction with the glucagon-like peptide 1 receptor (GLP1R), converted to the active state following interaction with the orthosteric non-peptide agonist danuglipron.</p><p>The revised version has improved clarity and rigor compared to the original also thanks to the reduction in the number of complex case studies treated superficially.</p><p>The mwSuMD method is solid and valuable, has wide applicability and is compatible with the most world-widely used MD engines. It may be of interest to the computational structural biology community.</p><p>The huge amount of high-resolution data on GPCRs makes those systems suitable, although challenging, for method validation and development.</p><p>While the approach is less energy-biased than other enhanced sampling methods, knowledge, at the atomic detail, of binding sites/interfaces and conformational states is needed to define the supervised metrics, the higher the resolution of such metrics is the more accurate the outcome is expected to be. Definition of the metrics is a user- and system-dependent process.</p></body></sub-article><sub-article article-type="referee-report" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96513.4.sa3</article-id><title-group><article-title>Reviewer #3 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>In the present work Deganutti et al. report a structural study on GPCR functional dynamics using a computational approach called supervised molecular dynamics.</p><p>Strengths:</p><p>The study has the potential to provide novel insight into GPCR functionality. An example is the interaction between D344 and R385 identified during the Gs coupling by GLP-1R. However, validation of the findings, even computationally through for instance in silico mutagenesis study, is advisable.</p><p>Weaknesses:</p><p>No significant advance of the existing structural data on GPCR and GPCR/G protein coupling is provided. Most of the results are reproductions of the previously reported structures.</p></body></sub-article><sub-article article-type="author-comment" id="sa4"><front-stub><article-id pub-id-type="doi">10.7554/eLife.96513.4.sa4</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Deganutti</surname><given-names>Giuseppe</given-names></name><role specific-use="author">Author</role><aff><institution>Coventry University</institution><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Pipito</surname><given-names>Ludovico</given-names></name><role specific-use="author">Author</role><aff><institution>Coventry University</institution><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Rujan</surname><given-names>Roxana Maria</given-names></name><role specific-use="author">Author</role><aff><institution>Coventry University</institution><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Weizmann</surname><given-names>Tal</given-names></name><role specific-use="author">Author</role><aff><institution>Coventry University</institution><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Griffin</surname><given-names>Peter</given-names></name><role specific-use="author">Author</role><aff><institution>Coventry University</institution><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff></contrib><contrib contrib-type="author"><name><surname>Ciancetta</surname><given-names>Antonella</given-names></name><role specific-use="author">Author</role><aff><institution>University of Ferrara</institution><addr-line><named-content content-type="city">Ferrara</named-content></addr-line><country>Italy</country></aff></contrib><contrib contrib-type="author"><name><surname>Moro</surname><given-names>Stefano</given-names></name><role specific-use="author">Author</role><aff><institution>University of Padua</institution><addr-line><named-content content-type="city">Padova</named-content></addr-line><country>Italy</country></aff></contrib><contrib contrib-type="author"><name><surname>Reynolds</surname><given-names>Christopher Arthur</given-names></name><role specific-use="author">Author</role><aff><institution>Coventry University</institution><addr-line><named-content content-type="city">Coventry</named-content></addr-line><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the previous reviews</p><disp-quote content-type="editor-comment"><p><bold>Public Reviews</bold>:</p><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>The authors investigate ligand and protein-binding processes in GPCRs (including dimerization) by the multiple walker supervised molecular dynamics method. The paper is interesting and it is very well written.</p><p>Strengths:</p><p>The authors' method is a powerful tool to gain insight on the structural basis for the pharmacology of G protein-coupled receptors.</p></disp-quote><p>We thank the Reviewer for the positive comment on the manuscript and the proposed methods.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>The study by Deganutti and co-workers is a methodological report on an adaptive sampling approach, multiple walker supervised molecular dynamics (mwSuMD), which represents an improved version of the previous SuMD.</p><p>Case-studies concern complex conformational transitions in a number of G protein Coupled Receptors (GPCRs) involving long time-scale motions such as binding-unbinding and collective motions of domains or portions. GPCRs are specialized GEFs (guanine nucleotide exchange factors) of heterotrimeric Gα proteins of the Ras GTPase superfamily. They constitute the largest superfamily of membrane proteins and are of central biomedical relevance as privileged targets of currently marketed drugs.</p><p>MwSuMD was exploited to address:</p><p>(a) binding and unbinding of the arginine-vasopressin (AVP) cyclic peptide agonist to the V2 vasopressin receptor (V2R);</p><p>(b) molecular recognition of the β2-adrenergic receptor (β2-AR) and heterotrimeric GDPbound Gs protein;</p><p>(c) molecular recognition of the A1-adenosine receptor (A1R) and palmotoylated and geranylgeranylated membrane-anchored heterotrimeric GDP-bound Gi protein;</p><p>(d) the whole process of GDP release from membrane-anchored heterotrimeric Gs following interaction with the glucagon-like peptide 1 receptor (GLP1R), converted to the active state following interaction with the orthosteric non-peptide agonist danuglipron.</p><p>The revised version has improved clarity and rigor compared to the original also thanks to the reduction in the number of complex case studies treated superficially.</p><p>The mwSuMD method is solid and valuable, has wide applicability and is compatible with the most world-widely used MD engines. It may be of interest to the computational structural biology community.</p><p>The huge amount of high-resolution data on GPCRs makes those systems suitable, although challenging, for method validation and development.</p><p>While the approach is less energy-biased than other enhanced sampling methods, knowledge, at the atomic detail, of binding sites/interfaces and conformational states is needed to define the supervised metrics, the higher the resolution of such metrics is the more accurate the outcome is expected to be. Definition of the metrics is a user- and system-dependent process.</p></disp-quote><p>We thank the Reviewer for the positive comment on the revised manuscript and mwSuMD. We agree that the choice of supervised metrics is user- and systemdependent. We aim to improve this aspect in the future with the aid of interpretable machine learning.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Public review):</bold></p><p>Summary:</p><p>In the present work Deganutti et al. report a structural study on GPCR functional dynamics using a computational approach called supervised molecular dynamics.</p><p>Strengths:</p><p>The study has potential to provide novel insight into GPCR functionality. Example is the interaction between D344 and R385 identified during the Gs coupling by GLP-1R. However, validation of the findings, even computationally through for instance in silico mutagenesis study, is advisable.</p><p>Weaknesses:</p><p>No significant advance of the existing structural data on GPCR and GPCR/G protein coupling is provided. Most of the results are reproductions of the previously reported structures.</p></disp-quote><p>The method focus of our study (mwSuMD) is an enhancement of the supervised molecular dynamics that allows supervising two metrics at the same time and uses a score, rather than a tabù-like algorithm, for handing the simulation. Further changes are the seeding of parallel short replicas (walkers) rather than a series of short simulations, and the software implementation on different MD engines (e.g. Acemd, OpenMM, NAMD, Gromacs).</p><p>We agree with the Reviewer that experimental validation of the findings would be advisable, in line with any computational prediction. We are positive that future studies from our group employing mwSuMD will inform mutagenesis and BRET-based experiments.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>As for GLP1R, I remain convinced that the 7LCI would have been better as a reference for all simulations than 7LCJ, also because 7LCI holds a slightly more complete ECD.</p></disp-quote><p>We agree that 7LCJ would have been a better starting point than 7LCI for simulations because it presents the stalk region, contrary to 7LCJ. However, we do not think it might have influenced the output because the stalk is the most flexible segment of GLP1R, and any initial conformation is usually not retained during MD simulations.</p><disp-quote content-type="editor-comment"><p>Please, correct everywhere the definition of the 6LN2 structure of GPL1R as a ligand-free or apo, because that structure is indeed bound to a negative allosteric modulator docked on the cytosolic end of helix-6</p></disp-quote><p>We thank the reviewer for this precision. The text has been modified accordingly.</p><disp-quote content-type="editor-comment"><p>As for the beta2-AR, the &quot;full-length&quot; AlphaFold model downloaded from the GPCRdb is not an intermediate active state because it is very similar to the receptor in the 3SN6 complex with Gs. Please, eliminate the inappropriate and speculative adjective &quot;intermediate&quot;.</p></disp-quote><p>We have changed “intermediate” to “not fully active”, which is less speculative since full activation can be achieved only in the presence of the G protein.</p><disp-quote content-type="editor-comment"><p>Incidentally, in that model, the C-tail, eliminated by the authors, is completely wrong and occupies the G protein binding site. It is not clear to me the reason why the authors preferred to used an AlphaFold model as an input of simulations rather than a high resolution structural model, e.g. 4LDO. Perhaps, the reason is that all ICL regions, including ICL3, were modeled by AlphaFold even if with low confidence. I disagree with that choice.</p></disp-quote><p>We understand the reviewer’s point of view. Should we have simulated an “equilibrium” receptor-ligand complex, we would have made the same choice. However, the conformational changes occurring during a G protein binding are so consistent that the starting conformation of the receptor becomes almost irrelevant as long as a sensate structure is used.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #3 (Recommendations for the authors):</bold></p><p>The revised version of the manuscript is more concise, focusing only on two systems. However, the authors have responded superficially to the reviewers' comments, merely deleting sections of text, making minor corrections, or adding small additions to the text. In particular, the authors have not addressed the main critical points raised by both Reviewer 2 and Reviewer 3.</p><p>For example, the RMSD values for the binding of PF06882961 to GLP-1R remain high, raising doubts about the predictive capabilities of the method, at least for this type of system.</p><p>What is the RMSD of the ligand relative to the experimental pose obtained in the simulations? This value must be included in the text.</p></disp-quote><p>We have added this piece of information about PF06882961 RMSD in the text, which on page 6 now reads “We simulated the binding of PF06882961, reaching an RMSD to its bound conformation in 7LCJ of 3.79 +- 0.83 Å (computed on the second half of the merged trajectory, superimposing on GLP-1R Ca atoms of TMD residues 150 to 390), using multistep supervision on different system metrics (Figure 2) to model the structural hallmark of GLP-1R activation (Video S5, Video S6).”</p><disp-quote content-type="editor-comment"><p>Similarly, the activation mechanism of GLP-1R is only partially simulated.</p><p>Furthermore, it is not particularly meaningful to justify the high RMSD values of the SuMD simulations for the binding of Gs to GLP-1R by comparing them with those reported under unbiased MD conditions. &quot;Replica 2, in particular, well reproduced the cryo-EM GLP-1R complex as suggested by RMSDs to 7LCI of 7.59{plus minus}1.58Å, 12.15{plus minus}2.13Å, and 13.73{plus minus}2.24Å for Gα, Gβ, and Gγ respectively. Such values are not far from the RMSDs measured in our previous simulations of GLP-1R in complex with Gs and GLP-149 (Gα = 6.18 {plus minus} 2.40 Å; Gβ = 7.22 {plus minus} 3.12 Å; Gγ = 9.30 {plus minus} 3.65 Å), which indicates overall higher flexibility of Gβ and Gγ compared to Gα, which acts as a sort of fulcrum bound to GLP-1R.&quot;</p><p>Without delving into the accuracy of the various calculations, the authors should acknowledge that comparing protein structures with such high RMSD values has no meaningful significance in terms of convergence toward the same three-dimensional structure.</p></disp-quote><p>The text has been edited to accommodate the reviewer’s suggestion and still give the readers the measure of the high flexibility of Gs bound to GLP-1R. It now reads “Such values do not support convergence with the static experimental structure but are not far from the RMSDs measured in our previous simulations of GLP-1R in complex with G<sub>s</sub> and GLP-1 (G<sub>α</sub> = 6.18 ± 2.40 Å; G<sub>b</sub> = 7.22 ± 3.12 Å; G<sub>g</sub> = 9.30 ± 3.65 Å), which indicates overall higher flexibility of G<sub>b</sub> and G<sub>g</sub> compared to G<sub>α</sub>, which acts as a sort of fulcrum bound to GLP-1R.”</p><disp-quote content-type="editor-comment"><p>Have the authors simulated the binding of the Gs protein using the experimentally active structure of GLP-1R in complex with the ligand PF06882961 (PDB ID 7LCJ)? Such a simulation would be useful to assess the quality of the binding simulation of Gs to the GLP1R/PF06882961 complex obtained from the previous SuMD.</p></disp-quote><p>We considered performing the Gs binding simulation to the active structure of GLP-1R.</p><p>However, the GLP-1R (and other class B receptors) fully active state, as reported in 7LCJ, depends on the presence of the Gs and can be reached only upon effector coupling. Since it is unlikely that the unbound receptor is already in the fully active state, we reasoned that considering it as a starting point for Gs binding simulations would have been an artifact.</p><disp-quote content-type="editor-comment"><p>An example of the insufficient depth of the authors' replies can be seen in their response: &quot;We note that among the suggested references, only Mafi et al report about a simulated G protein (in a pre-formed complex) and none of the work sampled TM6 rotation without input of energy.&quot;</p><p>This statement is inaccurate. For instance, D'Amore et al. (Chem 2024, doi: 10.1016/j.chempr.2024.08.004) simulated Gs coupling to A2A as well as TM6 rotation, as did Maria-Solano and Choi (eLife 2023, doi: 10.7554/eLife.90773.1). The former employed path collective variables metadynamics, which is not cited in the introduction or the discussion, despite its relevance to the methodologies mentioned.</p></disp-quote><p>Respectfully, our previous reply is correct, as all of the mentioned articles used enhanced (energy-biased) approaches, so the claim “none of the work sampled TM6 rotation without input of energy” stands. The reference to D’Amore et al. (published after the previous round of reviews of this manuscript) has been added to the introduction; we thank the reviewer for pointing it out.</p><disp-quote content-type="editor-comment"><p>Additionally, SuMD employs a tabu algorithm that applies geometric supervision to the simulation, serving as an alternative approach to enhancing sampling compared to the &quot;input of energy&quot; techniques as called by the authors. A fair discussion should clearly acknowledge this aspect of the SuMD methodology.</p></disp-quote><p>We have now specified in the Methods that a tabù-like algorithm is part of SuMD, which, despite being the parent technique of mwSuMD, is not the focus of the present work. We provide extended references for readers interested in SuMD. mwSuMD, on the other hand, does not use a tabù-like algorithm but rather a continuative approach based on a score to select the best walker for each batch, as described in the Methods.</p></body></sub-article></article>